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ABSTRACT 
Influenza A virus Reassortment and Genome Packaging 
by 
Graham D. Williams 
Doctor of Philosophy in Biology and Biomedical Sciences 
Molecular Microbiology and Microbial Pathogenesis 
Washington University in St. Louis, 2017 
Professor Adrianus Boon, Chair 
 
Influenza A viruses (IAV) are a major human and environmental pathogen. IAV 
successfully infects a diverse host range and adaptation of new viral strains to humans may cause 
pandemic events with high morbidity and mortality. As a member of the Orthomyxoviridae 
family, IAV inherently possesses a segmented genome, which enables a process of segment 
transmission between viruses following cellular co-infection, a process termed reassortment. The 
high rate of IAV mutation and continued co-circulation of diverse viral strains in divergent host 
species leads to the persistent prospect for emergence of new IAV with pandemic potential. 
Therefore, it is of great importance to understand the viral and host factors that restrict and 
promote the generation of emergent virus strains, their potential for pathogenesis, and discover 
novel mechanistic countermeasures against IAV, including improved vaccination and targeted 
therapeutic strategies.  
Human and avian IAV co-circulate and occasionally co-infect the same host, leading to 
the potential for generation of novel genome constellations following reassortment. The specific 
host and viral molecular determinants that allow replication of reassortant progeny virus are not 
well defined. Here, I show that the viral genetic context and host cell in which reassortment 
occurs determine the potential for genetic diversity derived from multiple distantly related 
strains. Importantly, we identify single gene reassortants between a North American avian strain 
and the 2009 pandemic H1N1 virus that are capable of causing disease in mammals and replicate 
in a human cell line as well as induce the production of several pro-inflammatory cytokines 
linked to severe disease outcomes. Additionally, utilizing a different viral genetic background, I 
show that the reassortment potential is regulated by species and cell type specific differences in 
 ix 
viral replication due to augmented viral polymerase function dependent on the identity of a 
single amino acid in the PA protein. Together, these studies provide evidence that context-
dependent compatibility between both viral and host factors determine the possibility for 
generation of novel reassortant genome constellations and regulate their potential for replication 
and transmission in new host species.  
Reassortment between IAV strains is likely dictated by the functional compatibility of 
vRNA segments bound by IAV nucleoprotein during genome packaging. I hypothesized that 
nucleoprotein (NP) scaffolds specific RNA elements that are required for genome packaging and 
interaction between viral RNA (vRNA) genome segments. Therefore, I sought to determine the 
functional consequences of genome architecture on genome packaging and for the first time 
determine the nucleotide-resolution landscape of NP-vRNA interactions in infected cells. We 
utilized Photoactivatable Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation 
(PAR-CLIP) coupled to next-generation sequencing to determine the specific interaction sites  of 
vRNA bound by NP. We then interrogated the functional importance of regions of vRNA bound 
or unbound by NP and identified a number of potentially structured RNA features required for 
efficient genome packaging and virus propagation. These studies provide a framework for 
understanding the multifactorial restrictions of IAV reassortment and potential for generation of 
novel genome constellations with pandemic potential. Finally, these studies expand our 
understanding of how viral and host determinants shape the possible evolutionary trajectories of 
IAV through reassortment and required genetic elements needed for genome assembly.  
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CHAPTER 1: 
INTRODUCTION  
 2 
1.1 Influenza A virus as a Cause of Human and Animal Disease 
Influenzavirus A viruses are part of the Orthomyxoviridae family that also consists of related 
but distinct members including Influenzavirus B, Influenzavirus C, Thogotovirus, and Isavirus1. 
While Influenza A, B, and C genera and Thogotoviruses infect humans and a wide variety of 
other organisms, Isaviruses are presently understood as restricted to aquatic vertebrates. 
Influenza A (IAV) and B (IBV) viruses pose the greatest risk to humans. IAV can infect a highly 
divergent cohort of birds, humans, domestic pigs, horses, dogs, and aquatic mammals but 
influenza B virus is restricted to humans.  
Influenza infection in humans is generally limited to the respiratory epithelium, although 
dissemination to other organs has been observed in some highly pathogenic strains2,3. 
Transmission of the virus occurs by respiratory droplet as well as contact with contaminated 
surfaces. High population density (i.e. schools or workplaces) and direct exposure to infected 
individuals leads to increased transmission of the disease4. As a respiratory pathogen, the 
mucosal epithelial surface and innate immune system play large roles in host protection5. In dry 
air, mucous in the airway is thinned and leads to greater likelihood of infection6. Influenza 
pathogenesis is mediated by immune infiltration and inflammation in the airway as well as 
enhanced inflammatory cytokine release leading to edema at the sites of infection and 
replication7. Symptoms consist of coughing, fever, rhinitis, and malaise occurring within 2 days 
of exposure that general resolve within 7-10 days. Viral shedding and contagiousness may occur 
before the onset of symptoms making disease control and spread a large public health issue.  
1.2 Influenza A Ecology and Zoonosis 
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IAV is a genetically diverse viral species, presently including 17 HA subtypes and 10 NA 
subtypes, classified by both differential immune recognition and sequence composition8. H1N1, 
H3N2, and H2N2 subtypes have circulated widely in the human population, while other subtypes 
are largely restricted to other mammals or the natural reservoir of migratory and shore birds9. 
Avian IAV including subtypes H5, H7, and H9 cause sporadic, sometimes fatal disease in 
humans and are major agricultural pathogens10.  Zoonosis of these viruses or derivative lineages 
formed by reassortment with human transmissible strains may lead to the emergence of viruses 
with pandemic potential11–13. Therefore, it is of great importance to determine the molecular basis 
of replication and pathogenesis of contemporary avian viruses in the mammalian host. IAV’s 
containing subtype H7 Hemagglutanin may pose the greatest threat to human health beyond 
seasonal influenzas of subtypes H1 and H314. In the past decade there have been multiple 
outbreaks of H7N1, H7N3, and most recent H7N9 viruses in avian and human populations15–17. 
These outbreaks are geographically distinct and are not the result of movement of viruses across 
geographic regions.   
Encounters with H7 viruses are likely common in human populations, though substantial 
adaptation may have to occur before they can cause fulminant respiratory disease.  
Seroprevalence studies in Italy, China, and North America reveal the presence of antibodies to 
H7 (at least H7 cross-reactive) antibodies in many people18. Additional human cases in North 
America have been documented. A small 2004 outbreak in British Columbia resulted in the 
infection of two poultry workers19.  
In addition to these low-pathogenic strains (LPAIs), the H7 subtype may harbor a multi-
basic cleavage site (MBCS) found in highly-pathogenic strains (HPAIs)20. Interestingly, these 
strains are able to acquire this cleavage signal likely through recombination with host rRNA. 
 4 
During 2012-2013 a highly pathogenic H7N3 strain in Mexico acquired an MBCS through 
inclusion of a 11 amino acid sequence immediately proximal to the H0-H1 cleavage site. The 
resulting virus is more pathogenic in Galliformes and can cause disease in mammals as 
evidenced by multiple infections as a result of occupational exposure.  
North American H7 viruses isolated from aquatic birds have receptor binding affinity to 
human-like sialic acids 19. Additionally, most humans are not seroreactive to H7-HA and this 
population-level naivety, and lack of neutralizing antibodies, may allow rapid spread of a greater 
outbreak than potentially a moderately, antigenically distinct H1 or H3. Both H7- and H1-
subtype viruses are capable of infecting mammalian hosts. As both H7 and H1 subtype viruses 
co-circulate geographically, there is the possibility that reassortment a process described below, 
between the viruses may result in a strain with altered properties11.  
1.3 Genome Reassortment Produces Pandemic Influenza Viruses 
IAV possess a genome composed of eight single-stranded negative-sense RNA segments 
encapsulated in a nucleoprotein coat and polymerase complex packaged in a host-cell derived 
envelope21. In the event of cellular coinfection, viral ribonucleoprotein complexes (vRNPs) from 
multiple strains of the virus are able to simultaneously utilize the host cell for replication and 
genome packaging. If a mixed genome is successfully packaged, resulting viruses with segments 
from both parental strains result - giving rise to a new genome constellation9. This process, 
termed reassortment, is one of the evolutionary strategies employed by IAV to produce new viral 
strains that may have altered replication, pathogenesis, and transmission profiles when compared 
to previous isolates. For reassortment to be successful new genomic constellations must be 
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replication competent and when there is little difference between constituent segments of two 
viruses reassortment may occur at a high frequency.  
Influenza reassortment has led to the generation of multiple viruses capable of generating 
pandemics22–25. Requisite for pandemic formation is the ability of the virus to break animal-to-
human transmission barriers, replicate and release efficiently in the human host, and transmit 
form human-to-human26. The profound effect of reassortment may be illustrated by inspecting 
the phylogeny of pandemic IAVs from 1918 to 2009 and the recently emergent H7N927,28.  In 
each case an antigenically distinct HA was acquired by way of reassortment with a virus capable 
of transmitting to and replicating in humans29,30. Humoral immunity to HA is the primary basis of 
current vaccination strategies and antigenic shift of HA by reassortment alters recognition by 
antibodies. The 1918 H1N1 "Spanish Flu" was likely created by reassortment of at least one 
avian virus and a mammalian virus that circulated in porcine hosts before introduction to 
humans31,32. Between 20-50 million people died as a result of primary influenza infection and 
subsequent secondary pneumonia. Contemporary segments with high homology to the 1918 
H1N1 strain persist in both avian and swine populations27. Experimental creation of an H1N1 
strain derived from currently circulating avian genome segments was also shown to cause severe 
disease in mammals and can transmit between ferrets. Moreover, reassortment between human 
and avian IAV, likely in a porcine vessel, resulted in the generation of H2N2 and H3N2 strains 
that caused pandemics in 1957 and 1968, respectively. H3N2 viruses have continued to circulate 
following the pandemic and are, along with H1N1, the primary cause of seasonal epidemics.  
Prior to each pandemic, antigenic shift of HA or NA occurred in addition to transfer of 
internal gene segments. The 2009 pandemic H1N1 emerged following at least three independent 
reassortment events involving human, porcine, and avian viruses32. The compatibility of genome 
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segments from this virus with both high and low pathogenic contemporary avian influenza 
viruses in experimental settings is concerning. Mammal-to-mammal transmission of non-adapted 
single gene reassortants has been experimentally demonstrated4,11,13,33,34. Reassortment of IAV 
viruses occurs readily in nature and may be simulated in the lab using either co-infection or 
forced reverse genetic approaches. 
Many recent studies have assessed the effect of reassortment between 2009 pandemic 
H1N1 and other virus strains. In many cases reassortment resulted in increased pathogenesis of 
porcine viruses. Additionally, many cases of reassortment between 2009 pandemic H1N1 and 
endemic porcine viruses have been documented. Paired with the potential for reassortment with 
wild aquatic birds, shorebirds and mallards included, investigation of the potential for 
reassortment and altered pathogenesis in LPAI H7 viruses with the 2009 pandemic H1N1 virus 
are imperative. For instance, does the acquisition of structural or non-structural genes from 
human viruses lead to increased replication, pathogenesis, or transmission of environmentally 
obtained North American avian influenza viruses? This question will be partially addressed by 
Chapter 2 of this thesis.  
1.4 IAV Genome Structure and Virally Encoded Proteins 
Upon infection of the host cell, negative-sense genome segments are trafficked to the 
nucleus and generate a positive-sense RNA intermediate that acts as a template for genome 
replication and may be enzymatically modified to serve as message for translation of viral 
proteins35. Influenza viruses possess an RNA-dependent RNA Polymerase (RdRP) complex that 
also facilitates an endonucleolytic cap-snatching mechanism for co-opting the host 
transcriptional machinery to produce viral proteins.36 Individual IAV particles are thought to 
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contain one copy of each of the eight genomic segments37,38. The proportion of infectious to 
defective particles created during infection remains controversial, potentially a consequence of 
inefficient genome packaging39. Encoded by these eight segments are at least 12 functionally 
distinct proteins: PB2, PB1, PB1-F2, PA, PA-X, HA, NP, NA, M1, M2, NS1, and NEP (NS2) 
(Table 1.1)1. PB2, PB1, and PA along with NP compose the viral replication machinery. HA and 
NA are surface glycoproteins associated with host cell attachment and budding respectively34. 
The nonstructural proteins NS1 and NEP act, respectively, as regulators of the host immune 
response and in export of vRNPs from the nucleus40,41. All of these proteins intimately interact 
with host cellular components during the course of entry, endosomal fusion, replication, and 
budding leading to dissemination of the virus and pathogenic features of infection (Figure 1.1)42. 
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Segment 
(length, nt) Protein Primary Function 
 
1 (2341) 
 
 
PB2 
 
Cap-binding domain of RdRP* 
 
2 (2341) 
 
PB1 
 
PB1-F2 
 
Catalytic subunit of RdRP 
 
Pro-apoptotic, immune modulatory 
 
3 (2233) 
 
PA 
 
PA-X 
 
Cap-snatching endonuclease in RdRP 
 
Host cell shut-off, “non-specific” endonuclease, 
immune modulation 
 
4 (1775) 
 
 
HA 
 
Surface glycoprotein, host cell attachment, 
membrane fusion 
 
5  (1565) 
 
NP Nucleoprotein, encapsidation of viral RNAs 
 
6 (1413) 
 
 
NA 
 
Surface glycoprotein, Neuraminidase activity, 
receptor destruction and particle egress from host 
cell 
 
7 (1027) 
 
M1 
 
M2 
 
Matrix protein, particle morphology, vRNP export 
 
Surface cation channel, protects HA conformation 
 
8 (890) 
 
NS1 
 
 
NEP (NS2) 
 
Regulation of RdRP, Interferon antagonist, 
enhancement of viral mRNA translation 
 
Nuclear export factor 
 
Table 1.1. Proteins encoded by each IAV segment and ascribed functions. 
*RdRP: RNA-dependent RNA polymerase 
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1.5 IAV Receptor Binding, Entry, Endosomal Fusion and Uncoating 
IAV has a class I fusion protein, Hemagglutinin (HA), that adorns the viral envelope43. 
HA binds sialic acid moieties on the host cell surface and is internalized by a variety of 
pathways44,45. Spherical viruses generally enter through clathrin-dependent, receptor-mediated 
endocytosis of the virus followed by passage through the endocytic pathway concluding with 
fusion in the late endosome at low-pH46. Filamentous influenza A viruses enter the cell via a 
clathrin-independent, dynamin-independent pathway44,47. HA induces membrane fusion between 
viral and host membrane and M2 activation occurs and viral acidification induces separation of 
M1 and vRNPs allowing their export to the cytoplasm and subsequently the nucleus48.  
1.6 vRNP transport to the Host Cell Nucleus 
Following fusion and uncoating, vRNPs must traverse the cytoplasm prior to nuclear 
entry49. In the cytoplasm vRNPs are individually bound by importin-alpha proteins that 
recognized nuclear localization signals within viral proteins. After importin-alpha loading, an 
active transport process involving host Ran-GTPases allows traversal of the nuclear pore 
complex50. The recognition by importin-alpha likely relies on a non-classical NLS in the solvent 
exposed N-terminus of NP present at high copy number within vRNPs35. Additionally, PB2 is 
known to interact with host importins as well, though at only one copy per vRNP, the 
contribution of these interactions to nuclear import remain unclear.  
 
  
 10 
 
 
Figure 1.1. Schematic of the influenza A virus infection cycle. Adapted from Shi, et al. 
Nature Reviews Microbiology. 20131. IAV particles bind host-derived sialic acids via HA and 
induce virus uptake at the cell membrane. IAV is trafficked to the late endosome prior to pH-
dependent HA fusion in the endolysosome. Particle uncoating occurs as M2 is activated and M1 
detaches from vRNPs, allowing their export to the host cytoplasm. vRNPs are transported to the 
nucleus via host proteins and cross the nuclear pore complex and pioneer transcription and 
protein production proceed. Following accumulation of proteins involved in genome replication, 
a positive-sense replication intermediate (cRNP) is generated from vRNA template, and then 
transcription of nascent vRNPs proceeds and amplifies viral RNA content in the nucleus. vRNPs 
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are actively transported from the nucleus to the cytoplasm where they assemble as multi-
segmented foci at Rab11a-positive vesicles and are trafficked en masse to the interior of the 
plasma membrane at sites of viral budding. Progeny virus bud from the cell membrane and via 
M2-dependent scission thereby enabling release from the cell. 
1.7 Viral Protein synthesis, Cap-snatching, and Genome Replication 
Following nuclear import, the initial round of primary transcription from vRNA to viral 
mRNA must occur. Primary transcription is initiated by trans-acting vRNPs to facilitate (+)-
strand synthesis aided by many cellular factors including RNA polymerase II51. For viral mRNA 
to be produced and translated, a host-derived 5’leader sequence must be appended to the end of 
(+)-strand viral RNA. This process, termed cap-snatching, occurs via the endonucleitic cleavage 
of host mRNAs, via PA, following cap recognition by PB2 in the context of the heterotrimeric 
polymerase complex36. The first 10-15 nucleotides of host RNA are appended to the viral RNA 
and used as a template for translation following export from the nucleus52. A 3’-poly-A tail is 
added by the host protein SFPQ and splicing of certain viral mRNAs occurs53. In the case of viral 
transcripts lacking splice variants, these molecules are transported via the canonical host export 
pathways including NXF154. For transcripts that possess retained introns (M1 and NS1), NS1 
protein is required for efficient export due to occlusion of binding by host transcript quality 
control proteins and the proofreading machinery54,55. Once exported the host ribosome translates 
viral proteins. Each newly synthesized polymerase complex component must then be imported to 
the nucleus for continued replication41. Multiple host factors function in concert with the viral 
polymerase complex to transcribe and replication genomes56,57. After buildup of viral proteins, 
cRNA production begins and continues processively with the help of the cellular 
minichromosome maintenance complex, a helicase and clamp complex which allows extended 
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unwinding and synthesis along full-length transcripts58. Once unmodified cRNA is generated, it 
is used as a copy-back template to synthesize vRNA to be packaged into progeny virions. In both 
cases the synthesis of cRNA and vRNA likely occurs via RNP non-resident polymerase 
complexes59. As RNA synthesis via the heterotrimeric polymerase component, PB1 proceeds 
rapidly, it is possible nearly co-transcriptional coating of vRNA by NP may occur35. As NP 
oligomerization along vRNA may happen slower than synthesis, local RNA structures may form. 
These structures may facilitate potential inter-segment interactions to be discussed later in this 
text.  
1.8 vRNP Export and Transit to Budding Virion 
Following vRNP synthesis, genome segments must be actively exported from the nucleus 
to the sites of virus particle assembly. M1 participates in the transport of viral RNPs (vRNPs) 
across the nuclear compartment by bridging the vRNP and NEP (NS2)40,60,61. This export process 
is CRM1 and nuclear pore dependent. Following export of the CRM1-NEP-M1-vRNP complex 
from the nucleus, PB2 in the vRNP associates with a virus-induced Rab11a-positive vesicle41,62,63. 
Docking of vRNPs at this structure has shown to be dependent on vRNP-associated PB2 binding 
host Rab11a. At this point, or before, higher order clusters of vRNPs form in the cytoplasm64. 
The basis for molecular clustering remains undetermined but this portion of genome assembly 
provides a platform for competition between genome segments65. As subgenomic packets of 
vRNPs can be found directly following nuclear export, it seems likely that once vRNPs are 
loaded onto these transport vesicles via PB2, the local concentration of vRNPs is great enough 
for assembly of higher order, complete genomes. These interactions may occur via vRNA-vRNA 
interactions, in trans, between vRNPs and be potentiated by proximity66–68. 
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1.9 Influenza A Genome Segment and RNP Architecture 
Each vRNA genome segment contains at least one open reading frame (ORF), and two 
distal untranslated regions69–72. The 5’ and 3’ UTR, along with an overlapping portion of the ORF 
are responsible for packaging of the segment into progeny viruses. Segment termini all contain a 
universal 12 and 13 nucleotides, 5’ and 3’ respectively, that are nearly complementary and form 
a corkscrew-like promoter implicated in priming of cRNA and vRNA synthesis by the 
polymerase complex composed of PB2, PB1, and PA49,73,74.  
 IAV RNP complexes are comprised of the heterotrimeric polymerase complex as well as 
viral nucleoprotein and RNA. Using a number of methods, including mass-spectrometry and 
cryo-electron microscopy (EM), nucleoprotein has been hypothesized to bind approximately 24-
32 bases per monomer by calculating the number of NP monomers per polymerase in purified 
virus or by dividing the length of a segment by the number of NP molecules present59,69,75,76. 
Conversely, NP spontaneously assembles into vRNP-like helical structures in the presence of 11-
13 nucleotides, and this discrepancy has not been fully reconciled77. Modeling of NP-RNA 
interactions additionally predicts the phosphate backbone of a 12 nucleotide model RNA may be 
accommodates in the positively charged RNA-binding groove of monomeric NP78. 
Reconstruction of vRNPs via cryo-EM describe these macromolecules as extended helical 
structures in which the opposing termini of each segment are coordinated by the polymerase 
complex. Nucleoprotein coils through interactions of a dimer interface along the segment length 
save for a structurally required loop in the segment end distal to the polymerase complex. NP 
binds to the phosphate backbone of vRNA in a manner that leaves bases exposed to solvent and 
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potentially able to form RNA structures in the context of the vRNP, suggesting NP coating of 
vRNA may be incomplete72,79. The structural approaches utilized to date have not quantified the 
specific nucleotide interactions of vRNA with NP in the context of infected cells or purified 
virus since the resolution limit of prior studies was not great enough to assign nucleotide 
identities to vRNA density in class-averaged cryo-EM structures59,69. Additionally, single particle 
cryo-EM studies demonstrate the potential for non-uniform helical torsion within vRNPs that 
generates heterogeneous structural topology71. Therefore, nucleotide resolution analysis of the 
NP-RNA interaction may elucidate previously unappreciated vRNP features required in IAV 
biology.  
1.10 Influenza A RNA Features Required for Coordinated Genome Packaging 
Segment specific packaging signals have been identified for each segment utilizing 
A/PR/08/1934 (H1N1) and A/WSN/1933 (H1N1) strains80–84. A/PR/08/1934 is the same strain of 
virus we have used in many studies and is also used as one of the genomic backgrounds for 
human vaccine development. Initial studies focused on internal truncations of large segments, 
primarily the polymerase coding segments that are able to compete with wild type segments for 
incorporation into the genome; these truncated segments have since been termed “Defective 
Interfering RNAs” (DI RNA)85. Importantly, these truncated segments were shown to act at the 
level of packaging, as they are able to compete with wild-type segments for incorporation into 
progeny viruses and result in replication incompetent virus. Additionally, though many reverse 
genetic experiments have examined the minimum requirements for DI-like RNA incorporation, 
most have found the inclusion of terminal coding regions in addition to conserved untranslated 
regions (UTR) confers a greater rate of incorporation relative to wild-type segments86. Similarly, 
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the inclusion of terminal coding regions promoted more efficient packaging than the UTR alone. 
More recently, reverse genetic studies employing artificial reporter segments have yielded 
valuable information about the minimal requirements for efficient packaging. All segments have 
demonstrated a requirement for a bipartite packaging signal derived from both segment termini87. 
Interestingly, in many cases truncation of one segment leads to a significant decrease in the 
packaging efficiency of other segments when measured on a segment-specific basis88. These 
results suggest the segments may function as a multipartite, cooperatively packaged entity rather 
than alone. This finding implies a bundling mechanism within the genome potentiated by 
segment- segment interactions.  
Information regarding structural features within the packaging signals and across entire 
segments is lacking and may provide insights into how such seemingly minute changes in 
sequence may have dramatic effects on replicative capacity89. Exposed vRNA may fold into 
conserved structures allowing between-segment interactions90. Indeed vRNA is moderately 
susceptible to RNase cleavage despite RNP formation, suggesting at minimum dynamic protein-
RNA interactions and potentially highly exposed, short RNA structures89. In support of this 
hypothesis complementary oligos targeting packaging regions are able to disrupt genome 
packaging and inhibit viral replication. Complex RNA structures may form within IAV vRNPs 
following co-transcriptional coating of RNA by nucleoprotein84. Consequently, the genome 
structure of IAV may be attributed to interactions between segments or an undiscovered RNA-
binding protein that is able to oligomerize genome segments following export from the nucleus. 
One hypothesis suggests that the packaging signals may contain the bundling and recognition 
motifs themselves. In this case RNA-RNA interactions between segments would be required for 
efficient packaging and accounting within a newly forming genome. Electron micrographs of 
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both IAV and Influenza B virus depict large regions of electron density that appear to extend 
between genome segments37. More recently, studies have implicated non-canonical packaging 
elements as critical for determining the relative selection rates of competing genome segments. 
Additional studies show a single-interaction network between in vitro transcribed vRNAs66,67,90. 
Interestingly, the interactions identified by this method differ by viral strain68. Further 
experiments have established that genome packaging is dependent on the genome constellation 
present at the time of packaging91,33,92,93. Experimental coinfection in vitro or by classical 
reassortment following coinfection and antibody selection, has demonstrated co-segregation of 
genome segments. For instance, during vaccine creation the seasonal NA and PB1 are found 
together at high frequency93. Most importantly, the description of vRNA interactions within this 
reports lie outside of the canonical packaging signals necessary for efficient incorporation of 
reporter genomic segments94. These studies and our preliminary data described above provide the 
basis for the following hypothesis: Interactions within and between vRNA segments drive 
packaging in a competitive context and therefore likely contribute greatly to the potential for 
reassortment during coinfection.  
1.11 Exploring viral and host determinants of reassortment potential 
The generation and continued replication of genetically diverse IAV in a wide range of 
host species presents and ongoing challenge for human and animal health10,26,95,96. Within the 
following chapters, three independent but interconnected studies describing in part the genetic 
features of IAV that enable, as well as restrict, viral propagation and the rise of new IAV strains 
are described. In chapter 2, I present a study on the potential for reassortment of a recent North 
American avian H7N3 isolate with a panel of human and avian virus strains91. The consequences 
of single-gene reassortment on viral replication pathogenesis in a mammalian model are 
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discussed. Subsequently, in chapter 3, studies examining the reassortment potential of a H1N1 
isolate demonstrate that the genetic context in which a gene segment resides may determine the 
fitness of a newly derived reassortant virus. In chapter 4, the interaction landscape of IAV NP 
and the viral genome are exported at nucleotide resolution. We find that the NP RNA scaffold 
likely allows formation of defined and required RNA structures that enable coordinated genome 
packaging. Finally, in chapter 5, the implications of our findings and recommendations for 
potential future studies are discussed in depth.  
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Chapter 2: 
A North American H7N3 influenza virus 
supports reassortment with 2009 pandemic 
H1N1 and induces disease in mice without 
prior adaptation 
 
  
 
 
This chapter was published in full as a research article in the Journal of Virology, a Journal of 
the American Society of Microbiology on 2 March 2016. 
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2.1 Abstract 
Reassortment between H5 or H9 subtype avian and mammalian influenza A viruses 
(IAV) can generate a novel virus that causes disease and transmits between mammals. This 
information is currently not available for H7 subtype viruses. We evaluated the ability of a low 
pathogenic North American avian H7N3 virus (A/shorebird/Delaware/22/2006) to reassort with 
mammalian or avian viruses using a plasmid-based competition assay. In addition to genome 
segments derived from an avian H7N9 virus, the H7N3 virus reassorted efficiently with the PB2, 
NA and M segments from the 2009 pandemic H1N1 (PH1N1) virus. In vitro and in vivo 
evaluation of the H7N3:PH1N1 7+1 reassortant viruses revealed that the PB2, NA, or M 
segments from PH1N1 largely do not attenuate the H7N3 virus, whereas the PB1, PA, NP, or NS 
genome segments from PH1N1 do. Additionally, we assessed the functionality of the 
H7N3:PH1N1 7+1 reassortant viruses by measuring the inflammatory response in vivo.  We 
found that infection with wild-type H7N3 resulted in increased inflammatory cytokine 
production relative to the PH1N1, which was further exacerbated by substitution of PH1N1 PB2 
but not NA or M. Finally, we assessed if any adaptations occurred in the individually substituted 
segments after in vivo inoculation and found no mutations suggesting PH1N1 PB2, NA, and M 
are genetically stable in background of this H7N3 virus. Taken together, we demonstrate that a 
North American avian H7N3 IAV is genetically and functionally compatible with multiple gene 
segments from the 2009 pandemic influenza virus strain without prior adaptation. 
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2.2 Importance 
The 2009 pandemic H1N1 continues to circulate and reassort with other influenza viruses 
creating novel viruses with increased replication and transmission potential in humans. Previous 
studies have found that this virus can also reassort with H5N1 and H9N2 avian influenza viruses. 
We now show that several genome segments of the 2009 H1N1 virus are also highly compatible 
with a low pathogenic avian H7N3 virus and that these reassortant viruses are stable and not 
attenuated in an animal model. These results highlight the potential for reassortment of H1N1 
viruses with avian influenza virus and emphasize the need for continued surveillance of 
influenza viruses in areas of co-circulation between avian, human and swine viruses. 
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2.3 Introduction 
Reassortment of influenza A viruses (IAV) produces diversity and antigenic novelty 
within circulating strains, sometimes leading to the emergence of pandemic viruses that cause 
widespread disease in humans. Avian IAV subtypes, including H5, H7, and H9, have caused 
sporadic but sometimes fatal disease in humans 1,2. Zoonosis of these viruses or derivative 
lineages formed via reassortment with strains capable of human-to-human transmission may lead 
to the emergence of novel viruses with pandemic potential 3. Indeed multiple avian-origin 
viruses, most notably H5N1 and H9N2 strains were able to cause disease in mammals and had 
limited, but enhanced transmission potential following experimental reassortment with the 2009 
pandemic H1N1 (PH1N1) 2,4. Genetically diverse IAV may therefore gain the ability to induce 
disease and transmit between mammals if an appropriate genetic constellation is assembled 
through reassortment.  
H7-subtype viruses intermittently infect and cause disease in humans following contact 
with infected birds 1,5. Outbreaks of H7 viruses in humans have occurred in geographically 
distinct areas including The Netherlands (2003), Canada (2004), Mexico (2012), and China 
(2013) 6. Sporadic infections such as these, that sometimes result in severe disease, suggests that 
introduction of a H7-subtype virus capable of sustained transmission between humans has the 
potential to initiate a significant outbreak. Recently, a reassortant, low pathogenic H7N9 virus 
emerged in China with a case-fatality rate of approximately 25%, making this the most severe 
and sustained incursion of H7-subtype viruses into the human population 7. Although person-to-
person transmission has not been consistently demonstrated, the virus is capable of limited 
transmission in guinea pig and ferret models without prior adaptation, suggesting the potential 
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acquisition of transmission-related adaptations through mutation or reassortment 7–10. The 
sustained and ongoing geographic co-circulation of H7-bearing viruses with the PH1N1 poses a 
risk for reassortment that may create H7-bearing viruses containing one or more PH1N1-origin 
gene segments 11.  
Reassortment of IAV genes, including those endemic in animal reservoirs has given rise 
to pandemic IAVs, most recently PH1N1 in 2009 12.  In each case, antigenic shift of external 
proteins occurred as well as transfer of gene segments encoding internal and nonstructural 
proteins. PH1N1 resulted from three independent reassortment events involving genes from 
swine, human, and avian viruses. This triple reassortant swine-origin IAV, first identified in 
Mexico, consists of PB2, PB1, PA, HA, NP, and NS derived from a North American swine virus 
isolate and the NA and M segment from an Eurasian lineage swine influenza virus 12. Further 
reassortment events between PH1N1 and swine IAV have resulted in the creation of variant 
H1N1v, H2N1v, and H3N2v viruses capable of causing disease in humans. All variant viruses 
contain segment 7 (M) of PH1N1, which has been shown to confer aerosol transmissibility to 
previously non-transmissible viruses 13,14. The widespread distribution of PH1N1 coupled with its 
high rate of reassortment with environmental viruses suggests the potential for the emergence of 
novel PH1N1 segment-containing IAV genome constellations with increased virulence or 
transmissibility in humans.  
North American H7N3 IAVs co-circulate with PH1N1; however, the ability of these avian 
viruses to reassort with PH1N1, modify virologic traits, and induce disease in mammals is not 
known. This study was initially designed to identify genome segments derived from diverse 
avian- and human-origin IAV that were most compatible with an avian-origin LPAI (low 
pathogenic avian influenza) H7N3 virus. We devised a competitive reverse genetics strategy to 
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examine selection of a single genome segment when multiple versions of that segment are 
present in a cell, mimicking cellular co-infection. We found PH1N1 PB2, NA, and M genome 
segments are capable of outcompeting the parental H7N3 strain and additional heterologous 
segments from diverse origins in competitive reverse genetic experiments.  As a result of the 
competitive reverse genetic studies, we generated and characterized the parental H7N3 and 
PH1N1 viruses, and seven H7N3:PH1N1 7+1 reassortant viruses. Characterization of single 
segment reassortants demonstrated multiple genome segments from PH1N1 either enhanced 
(PB2) or maintained (NA or M) H7N3 replication and virulence in a mouse model of infection. 
Finally, adaptation of substituted PH1N1 segments was not required to function within the H7N3 
backbone, suggesting these newly formed genomic constellations are genetically and 
functionally stable. 
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2.4 Materials and methods 
Biosafety and Ethical Considerations 
All experiments were carried out under enhanced BSL2 containment and approved by the 
Washington University in Saint Louis Institutional Biosafety Committee. The H7N3 virus 
A/shorebird/Delaware/22/2006 used in this study is neuraminidase inhibitor sensitive as are all 
the reassortant H7N3 viruses that were generated and used in this study. Additionally, the 
parental H7N3 virus has a genetic signature indicative of α-2,3-sialic acid (avian receptor) 
binding preference and does not bear a multibasic cleavage site, therefore we did not reasonably 
anticipate these experiments, in which this H7 HA was maintained, would result in increased 
host range or transmission to a new (mammalian) host. Finally, the NA gene of 
A/Memphis/03/2008 (H1N1) was excluded from this study due to a H274Y mutation that confers 
resistant to neuraminidase inhibitors (16).  
Viruses  
Viruses used in this study: A/shorebird/Delaware/22/2006 (H7N3), A/California/04/2009 
(PH1N1), A/mallard/Alberta/177/2004 (H7N9), A/Memphis/03/2008 (SH1N1), and A/Puerto 
Rico/08/1934 (PR8H1N1). For SH1N1, H7N3, and H7N9, cDNA for all gene segments was cloned 
into the bi-directional pHW2000 plasmid and used to generate influenza viruses as previously 
described (17). Dr. Richard Webby at St. Jude Children’s Research Hospital kindly provided the 
reverse genetic plasmids for PH1N1 and PR8H1N1. Plasmid-derived 
A/shorebird/Delaware/22/2006 (H7N3), A/California/04/2009 (PH1N1), and all H7N3:PH1N1 
7+1 single reassortant viruses, were generated using the 293T-Madin-Darby canine kidney cell 
(MDCK) co-culture system and supernatant was injected into 10-day old embryonated chicken 
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eggs for 48 hours at 35°C (Cackle Hatcheries, IA, USA). Allantoic fluid containing the 
infectious virus was harvested and stored at -80°C. The viral titer (tissue culture infectious dose 
50, TCID50) was determined using MDCK cells and viral stock used in this study was titrated at 
least twice independently. Single reassortant viruses on the background of H7N3 possessing a 
single genome segment from PH1N1 used in this study have been named with the following 
convention – seven segments from the H7N3 virus plus the substituted PH1N1 segment in 
subscript (ex. H7N3NA). 
Cells 
MDCK cells were maintained in Minimal essential medium (MEM) with 5% Fetal 
bovine serum (FBS), vitamins, L-glutamine (Invitrogen), penicillin, and streptomycin. 293T cells 
were maintained in Opti-MEM with 10% FBS, L-glutamine, penicillin and streptomycin. A549 
cells were maintained in Dulbecco’s Minimal essential medium (DMEM) with 10% FBS 
vitamins, L-glutamine, penicillin, streptomycin, 25mm HEPES, and non-essential amino acids 
(NEAA). 
Competitive Reverse Genetic Assay  
A competitive reverse genetic assay was developed to evaluate the ability of avian and 
human IAV genome segments to reassort in the context of an avian H7N3 viral background 
(Figure 1A). 293T-MDCK co-cultures were transfected with pHW2000 plasmids (1 µg per 
segment) containing seven genome segments of H7N3 virus plus four (for NA segment due to 
exclusion of NA from sH1N1) or five plasmids encoding a single genome segment (e.g. PB2) 
from different avian and human influenza viruses. All transfections included the wild-type H7N3 
segment in addition to those from divergent strains. We did not evaluate the HA genome 
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segment because of biosafety considerations. The total amount of co-transfected plasmid DNA 
for the 8th segment (1 µg) was divided equally between the four or five studied viruses including 
the parental strain. The DNA was mixed at a 1:2 ratio with Trans-IT LT1 (Mirus) in Opti-MEM 
for 20 minutes at room temperature and added to the culture medium. Following an overnight 
incubation, the cell culture medium was removed and 1ml of fresh Opti-MEM supplemented 
with penicillin, streptomycin, L-glutamine was added. Twenty-four hours later an additional 1ml 
of Opti-Mem with 1μg/ml TPCK-trypsin (Worthington) was added. Forty-eight hours later 
supernatants were collected, cell debris removed by centrifugation at 1,200xg, and frozen at -
80°C until further analysis. Clonal viral populations were isolated by limiting dilution assay on 
MDCK cells, then viral RNA extracted, reverse-transcribed using a vRNA-specific primer, and 
amplified with segment-specific PCR primers. Genome segment amplicons were genotyped by 
either restriction fragment length polymorphism analysis (RFLP) or Sanger sequencing. RFLP 
analysis was performed with one to four different restriction enzymes yielding a unique fragment 
length pattern for each segment and strain: PB2 (EcoRI, HindIII, BamHI); PB1 (HindIII); PA 
(BamHI, HindIII, XbaI); NP (BamHI, BglII); NA (BamHI, BglII, EcoRI, BsmBI); M (BamHI, 
HindIII, XcmI, PvuII). All restriction enzymes were obtained from New England Biolabs and 
used according to their instructions. The NS gene segment was genotyped by Sanger sequencing.  
Competitive reverse genetic assays were completed at least twice independently for each genome 
segment. On average we tested 48 clonal viruses per genome segment with a minimum of 24 (M 
segment) and maximum of 71 (PA segment) viruses.  
Virus Genome Sequence Analysis  
After expansion of virus in eggs, the nucleotide identity of the singly substituted genome 
segment in each H7N3:PH1N1 7+1 single reassortant virus was verified by Sanger sequencing. 
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Viral genomic RNA was extracted, and reverse transcribed as described above. Segment-specific 
PCR was conducted and the resulting amplicon was purified by Agarose gel electrophoresis, and 
then submitted to for sequencing with an overlapping panel of sequencing primers derived from 
the parental PH1N1 virus consensus sequence. We then assembled contiguous sequences for each 
segment and aligned them to the parental segment for analysis. The same sample preparation and 
analysis methods were used for materials derived from lung homogenate. 
Multistep Growth Curves of Influenza A virus 
MDCK or A549 cells (2x105) were seeded in 24-well plates and inoculated the next day 
with 50 TCID50 (MDCK) or 105 TCID50 (A549) of IAV. MDCK cells were washed once with 
PBS before adding the inoculum in MEM containing penicillin, streptomycin, L-glutamine, and 
vitamins plus 0.1% bovine serum albumin (M0.1B) for one hour at 37°C. After the one hour, the 
cells were washed once with PBS and 1.0 ml of M0.1B with 1µg/ml TPCK-trypsin was added to 
each well. A549 cells were washed once in DMEM containing penicillin, streptomycin, L-
glutamine, and vitamins plus 0.1% bovine serum albumin and NEAA (D0.1B) prior to 
inoculation with virus diluted in D0.1B. After one hour at 37°C, the A549 cells were washed 
once with D0.1B and 1.0 ml of D0.1B with 0.5µg/ml TPCK-trypsin was added to each well. 
Culture supernatants from either cell type were collected at 24 and 48 hours post-infection (hpi) 
and the amount of infectious virus was quantified by titration on MDCK cells. The results are the 
average of two to three experiments, each performed in duplicate. 
Phylogenetic analysis of IAV segments 
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Phylogenetic trees were generated for complete genome segments using the ClustalW 
algorithm in Lasergene MegAlign (version 11.1.0, DNASTAR, INC), bootstrapped 1000x, and 
used to constructed neighbor-joining phylogenetic trees. 
TCID50 assay 
Confluent monolayers of MDCK cells were grown overnight in 96-well plates. The next 
day, the cells were washed with PBS and inoculated with ten-fold serial dilutions (10-1 to 10-8) of 
culture supernatant, allantoic fluid or lung homogenate for one hour in M0.1B at 37°C and 5% 
CO2. After one hour the inoculum was removed and replaced with M0.1B supplemented with 
1µg/ml TPCK-trypsin and incubated for 72 hours. Presence of virus was determined by 
hemagglutination assay using 0.5% turkey red blood cells. TCID50 was determined by the Reed-
Muench method 15. 
Intranasal inoculation of mice with influenza viruses 
 Six- to eight-week-old male C57BL/6J mice were bred in-house in a barrier facility at 
Washington University School of Medicine, St Louis, MO, USA. The mice received food and 
water ad libitum and all experiments were conducted in accordance with rules of the Institutional 
Animal Care and Use Committee. Mice were inoculated with 103 or 104 TCID50 units of IAV 
intranasally in 30 µl of sterile PBS after sedation with Avertin (2,2,2-tribromoethanol, Sigma-
Aldrich, MO, USA). Morbidity and mortality following intranasal inoculation were monitored 
for 7 days (104 TCID50) or 14 days (103 TCID50). To assess lung viral titers, mice inoculated with 
104 TCID50 were sacrificed on days 3 or 7 post-inoculation, the entire lung was collected, 
homogenized in 1.0 ml of infection media, cleared by centrifugation at 1000xg for 5 minutes and 
stored in aliquots at –80°C. Experiments in which 104 TCID50 inoculum dose was used were 
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terminated at 7 days post-inoculation as all mice survived to the this point, at which viral titration 
and chemokine cytokine samples were harvested. Viral titers from lung homogenates were 
determined by TCID50 assay. The results from the lung titrations are the average of at least two 
independent experiments. 
Cytokine Array 
 Cytokine and chemokine production in lung homogenates was measured using a 23-plex 
cytokine array (Bio-Plex Pro™ Mouse Cytokine 23-plex Assay, Bio-Rad) according to 
manufacturer’s protocol. The cytokine screen included IL-1α, IL-1β, IL-2, IL-3 IL-4, IL-5, IL-6, 
IL-9, IL-10, IL-12p40, IL-12p70, IL-13, IL-17, Eotaxin, G-CSF, GM-CSF, IFN-γ, KC, MCP-1 
MIP-1α, MIP-1β, RANTES, and TNF-α. As many samples fell below the limit of detection we 
did not include the cytokines (IL-2, IL-3, IL-4, IL-9, and IL-17) in our analysis. Results from the 
cytokine array are the average of at least two independent experiments (Day 3: H7N3WT,n=6; 
H7N3PB2, n=5; H7N3NA, n=6, H7N3M, n=5; PH1N1WT, n=7; Day 7: H7N3WT, n=5; H7N3PB2, n=7; 
H7N3NA, n=7; H7N3M, n=4; PH1N1WT, n=10).  
Influenza A virus mini-genome reporter assay  
The PB2, PB1, PA and NP genes from H7N3 and PH1N1 were cloned into the 
pcDNA3.1+ (Invitrogen) mammalian expression vector from the corresponding pHW2000 
plasmid. The PA of pH1N1 containing the P295L mutation was cloned from the reassortant 
H7N3PA virus generated in this study. The pLuci plasmid was kindly provided by Dr. Yen (Hong 
Kong University, Hong Kong, China) and contains the firefly luciferase gene flanked by the non-
coding regions of NP gene segment in the negative orientation under the control of a human 
RNA polymerase I promoter. Cells were maintained at 37°C for the duration of the experiment. 
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A Renilla luciferase expression plasmid was included for normalization. 293T cells were seeded 
into 24-well plates and transfected with PB2, PB1, PA and NP expression plasmids 
(83ng/plasmid) along with the two luciferase containing plasmids (total of 500 ng DNA) using 
TransIT LT1 per well. The following day the media was changed and cells were incubated for 48 
hours, harvested and lysed for analysis of luciferase activities (Promega). Each combination of 
polymerase proteins (set of plasmids) was examined in duplicate and repeated independently in 
three separate experiments. The relative light units (RLU) of firefly luciferase activity were 
normalized to the RLU for Renilla luciferase activity within the same sample to account 
differences in transfection efficiency between wells and experiments. Polymerase activity was 
normalized to that of the parental H7N3 polymerase proteins. 
Statistical analysis 
All statistical analyses were performed using GraphPad Prism 6.0 software. Mann-Whitney U-
Test was used to determine statistical significance between lung virus titers. One-Way ANOVA 
with Dunnett’s Multiple Comparisons Test was used to determine statistical significance in 
cytokine and chemokine production in lung homogenates, with all comparisons made to H7N3WT 
for the indicated day. 2-Way ANOVA was used in the analysis of weight loss differences 
following influenza A virus infections in mice. Student’s T-test was used to assess statistical 
differences between conditions in the mini-genome reporter assay with all comparisons made to 
the wild-type combination of H7N3 proteins.  
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2.5 Results 
A North American H7 virus preferentially selects avian and 2009 pandemic H1N1 genome 
segments under competitive conditions. 
Previous studies examining reassortment potential between H5- and H9- subtype avian 
IAV and human-derived IAV report high compatibility between diverse avian and human origin 
genome segments 2,4,16,17.  However, it remains unclear if H7-subtype viruses can undergo similar 
reassortment events with other avian and human IAV. The recent emergence of H7N9 in China 
demonstrates that H7-subtype viruses can infect humans and, if they acquire the ability to 
transmit between humans through reassortment, may pose a significant public health threat.  
Therefore, we sought to determine if North American H7-subtype viruses are capable of 
extensive reassortment with human or mammalian viruses. 
We developed a competitive reverse genetics assay to evaluate the ability of heterologous 
genome segments from human and avian viruses to reassort efficiently with a North American 
low pathogenic H7N3 virus (Figure 2.1 A). Seven genome segments of 
A/shorebird/Delaware/22/2006 (H7N3) were maintained as a constant background while 
multiple versions of the 8th segment from H7N3, A/California/04/2009 (PH1N1), A/Puerto 
Rico/08/1934 (PR8H1N1), A/mallard/Alberta/144/2007 (H7N9), or A/Memphis/3/2008 (SH1N1) 
were included in equimolar ratios. Phylogenetic trees were constructed for each genome segment 
to illustrate the genetic relationship to the H7N3 segment (Figure 2.1 B). Pools of infectious 
viruses were rescued, subjected to limiting dilution assays to culture clonal viral populations, and 
identify the segment of interest by via RFLP or Sanger sequencing.   
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A total of 334 viruses were analyzed for 7 genome segments in the context of H7N3 virus 
(HA was excluded). We observed a high frequency of isolated viruses containing avian H7N3 
(29%) or H7N9 (34%) derived genome segments (Figure 2.1 B). In particular, the PB1, PA, NP 
and NS reassorted genome segments were predominantly (81%) of avian virus origin. In 
contrast, when we examined the identity of competitively selected segments the PB2, NA, and M 
genome segments were derived mostly from mammalian IAV, with a clear bias towards the 
PH1N1 virus. The NA gene of PH1N1 was identified in 100% (68/68) of the NA gene-reassorted 
H7 viruses, while the M and PB2 gene segment constituted 55% (13/24), and 35% (14/37) of the 
examined H7 viruses respectively. Combined, 32% of all isolated H7 viruses contained genome 
segments derived from PH1N1, suggesting a high degree of compatibility between H7N3 and 
PH1N1 virus. Genome segments from PR8H1N1 were identified sporadically, 5% (15/334), among 
the H7N3 viruses. Of these, 8 contained the PB2 gene of PR8H1N1. Finally, genome segments 
from SH1N1 were never identified, 0% (0/266), among the H7 viruses, suggesting a low level of 
genetic compatibility between human H1N1 viruses circulating prior to 2009 and avian H7N3 
virus.  
Most H7N3:PH1N1 7+1 viruses replicate efficiently in MDCK cells. 
We observed a high degree of genetic compatibility between genome segments of PH1N1 
and H7N3 viruses in our competitive reverse genetics assay and sought to determine the 
replicative ability of each single reassortant virus bearing individual PH1N1 segments in the 
background of H7N3. All 7+1 reassortant viruses were generated independently by reverse 
genetics and amplified in chicken eggs. We inoculated MDCK cells with 50 TCID50 and 
collected supernatant at 24 and 48 hpi (Figure 2.2 A and B, respectively). H7N3 virus replicates 
to high titers at 24 (107.8/ml) and 48 hpi (107.9/ml). In contrast, PH1N1 virus replicates to 
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significantly lower titers at 24 (105.8/ml) and 48 hpi (106.4/ml) (P<0.01 for both time-points). H7 
viruses containing the NA (H7N3NA) or M (H7N3M) gene segment of PH1N1 virus grow to 
similar titers (P>0.2) at 24 hpi (107.6/ml for H7N3NA and 107.3/ml for H7N3M) and 48 hpi (108.2/ml 
for H7N3NA and 108.1/ml for H7N3M). The titers of H7N3 reassortant viruses containing the PB2 
(H7N3PB2, 106.8/ml), PA (H7N3PA, 105.9/ml), NP (H7N3NP, 105.7/ml) or NS (H7N3NS, 106.3/ml) gene 
segment of PH1N1 were significantly (P<0.001) lower at 24 hpi, but not 48 hpi (P>0.15), 
compared to H7N3 parental virus. Finally, the virus titer of H7N3PB1 was significantly (P<0.001) 
lower at 24 and 48 hpi (104.4/ml and104.6/ml) compared to parental H7N3. Overall, our results 
indicate that most H7N3 viruses possessing a single genome segment of PH1N1 are able to 
replicate efficiently in a MDCK cell culture system and the NA and M gene of PH1N1 did not 
attenuate H7N3 virus in vitro.  
The majority of H7N3:PH1N1 7+1 viruses are attenuated in A549 cells. 
Next, we measured replication of the 7+1 reassortant viruses in a human lung epithelial 
cell line (A549). H7N3 virus replicated to 103.5 TCID50/ml at 24 hpi and 104.0 TCID50/ml at 48 
hpi. PH1N1 virus replicated to equivalent titers at 24 hpi (103.7 TCID50/ml) and significantly 
higher titers at 48 hpi (105.2 TCID50/ml, P<0.05) compared to H7N3 virus (Figure 2.2 C and D). 
H7N3 virus containing the M-segment of pH1N1 (H7N3M) was able to grow in A549 cells, albeit 
less efficient compared to the wild type H7N3 virus at 48 hpi (103.5 TCID50/ml, P<0.05). The 
7+1 reassortant virus containing the PB2 genome segment of PH1N1 replicated to equivalently 
titers at 24 hpi (103.7/ml), and higher titers at 48 hpi (104.7/ml, P<0.05), compared to H7N3 virus. 
Finally, we did not detect replicating virus from the H7N3PB1, H7N3PA, H7N3NP, H7N3NA, or 
H7N3NS reassortant viruses in culture supernatant at either time point post-inoculation. The data 
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suggest that the majority of the gene segments of PH1N1 attenuate H7N3 virus growth in human 
cells. 
PB2, PA, and NP segments of PH1N1 increase H7N3 polymerase activity in human cells. 
We employed a mini-genome reporter assay to assess the polymerase activity of different 
viral polymerase complexes in human 293T cells. We found that the full complement of PH1N1 
proteins generated greater reporter activity than did the H7N3 polymerase proteins (1.8-fold 
increase, P<0.01, Figure 2.3). Substitution of the PB2 or NP protein with those from PH1N1 
increased polymerase activity by 1.8-fold (P<0.01) and 1.4-fold (P<0.001) respectively. The PA 
of PH1N1 increased the polymerase activity more than 20-fold (P<0.001). We also evaluated a 
PA protein of PH1N1 containing a Proline to Leucine substitution at position 295 (P295L). This 
mutation was selected for in H7N3PA virus cultured in 10-day old embryonated chicken eggs. 
The polymerase activity of the mutant PA remained more than 10-fold (P<0.001, Figure 2.3) 
greater compared to H7N3 protein complex. Interestingly, substitution of PH1N1 PB1 into a 
majority H7N3 polymerase complex resulted in a 25-fold reduction in polymerase activity 
(P<0.001). To examine if this was due to strain-dependent differences in PB1 protein expression 
we analyzed protein expression by flow cytometry (mean fluorescence intensity (MFI)) using 
His-tagged versions of the PB1 of H7N3 and PH1N1 virus. We did not observe a difference in 
MFI between these two proteins (data not shown), suggesting that the 25-fold difference in 
reporter activity is due to inherent differences in compatibility between the polymerase proteins. 
Overall, the H7N3 virus appears well adapted to mammalian cells and the introduction of the 
PB1 of PH1N1 severely attenuates the H7N3 virus. 
H7N3:PH1N1 7+1 reassortant viruses induce distinct morbidities in vivo. 
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Given the high degree of functional compatibility between PH1N1 and H7N3 virus in 
vitro, we next determined the relative fitness of these H7N3 viruses containing individual gene-
segments of PH1N1 in vivo.  C57BL/6J mice were inoculated intranasally with either parental 
(H7N3 or PH1N1) or single segment reassortant viruses and weighed at regular intervals for one 
week (104 dose) or two weeks (103 dose) depending on the inoculum size. Mice inoculated with 
104 TCID50 of H7N3 demonstrated substantial weight loss beginning at 3 dpi (10%) that 
continued until the experiment was ended at 7 dpi (21%). Inoculation with 104 TCID50 of PH1N1 
induced up to 30% weight loss relative to the starting weight within 7 days (Figure 2.4 A) 
demonstrating that the PH1N1 is more pathogenic in mice compared to the avian H7N3 virus. 
H7N3 viruses containing single gene segments for PH1N1 varied in their ability to cause weight 
loss. Inoculation with 103 or 104 TCID50 of H7N3 virus containing the PB2 segment of PH1N1 
induced significantly (P<0.05) more weight loss compared to H7N3, including rapid weight loss 
(>20%) within the first three days following inoculation (Figure 2.4 A). Importantly, the 
H7N3PB2 virus was significantly (P<0.005, days 8 and 10; P<0.01, days 12, and 14) less virulent 
compared to the PH1N1 virus at the lower inoculum (Figure 2.4 D). Inoculation with 104 
H7N3NA or H7N3M resulted in equivalent weight loss at all times compared to H7N3 (Figure 2.4 
B, P>0.1). Reassortant H7N3 viruses possessing the PB1, PA, NP, or NS of PH1N1 did not 
induce appreciable weight loss at any day post inoculation, suggesting that these gene-segments 
from PH1N1 attenuate H7N3 virulence in vivo.  
H7N3 reassortant viruses possessing PH1N1 PB2, NA, or M do not attenuate replication in 
vivo. 
To further evaluate the compatibility between H7N3 and PH1N1 viruses we measured 
virus titer in lung tissue 3 and 7 dpi with 104 TCID50 of all parental and single gene reassortants. 
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Lung viral titers 3 days after PH1N1 virus inoculation (106.4/ml) were significantly higher 
(P<0.005) compared to H7N3 virus (105.9/ml, Figure 2.5 A). However, this difference in virus 
load disappeared by day 7; H7N3 (105.3/ml) and PH1N1 (105.7/ml) (P>0.15, Figure 2.5 B). The 
virus load in lungs of H7N3PB2 infected animals was significantly higher (106.5/ml, P<0.05) at 3 
dpi, but not 7 dpi (105.0/ml, P>0.15), compared to H7N3 virus.  Importantly, the viral load in 
H7N3PB2 infected lungs was similar to that of PH1N1 virus at day 3. Inoculation with H7N3NA or 
H7N3M resulted in similar lung virus titer compared to H7N3 at both 3 (105.7/ml for H7N3NA and 
105.5/ml for H7N3M) and 7 dpi (105.2/ml for H7N3NA and 104.3/ml for H7N3M), (P>0.05 for all 
comparisons). H7N3 reassortant viruses bearing PA or NS gene segment of PH1N1 replicated in 
vivo, however the virus titers were significantly lower at 3 (104.0/ml for H7N3PA and102.2/ml for 
H7N3NS, P<0.005 and P<0.01, respectively) and 7 dpi (102.0/ml for H7N3PA and102.0/ml for 
H7N3NS, P<0.005 and P<0.005, respectively) compared to H7N3 virus (Figure 2.5 A and B). 
Finally, H7N3NP and H7N3PB1 viruses were never detected at 3 or 7 dpi. These results suggest 
that the PB2, NA and M genes of PH1N1 are genetically and functionally compatible with the 
remaining segments of an avian H7 IAV. 
PH1N1 PB2, NA, or M show no signs of genetic adaptation in the context of a 
predominantly H7N3 genome constellation.  
We analyzed the nucleotide sequence of substituted PH1N1 gene segments in the context 
of the H7N3:PH1N1 7+1 viruses after passage in eggs and replication in mice. Six of the seven 
PH1N1 gene-segments contained no nucleotide changes upon culture in eggs. A single point 
mutation was found in the PA gene of PH1N1 (P295L) in H7N3PA grown 48 hours in eggs. This 
same mutation was identified a second time following an independent attempt to rescue virus 
with genetic sequence identical to the original PH1N1 PA gene. To analyze genetic stability in 
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vivo, we isolated RNA from lungs of mice infected 7 days with H7N3PB2 (n = 3), H7N3NA (n = 3), 
and H7N3M (n = 3). No nucleotide changes were found in any of the PB2, NA or M genes of 
PH1N1 in the context of the H7N3 virus. Taken together, these data suggest that the PH1N1 gene 
segments are genetically stable and highly functional in the context of an avian H7N3 virus. 
H7N3 and reassortant viruses that contain PH1N1 PB2, NA, or M viruses induce robust 
inflammatory cytokine and chemokine responses in vivo. 
The virulence and fitness of an influenza virus in the mouse model is often associated 
with elevated production of pro-inflammatory cytokines and chemokines 18–20. To further 
evaluate the functional compatibility between PH1N1 and H7N3 genes we quantified the 
inflammatory response in lung tissue 3 and 7 days post inoculation with the three most virulent 
H7N3:PH1N1 7+1 reassortant viruses (H7N3PB2, H7N3NA, and H7N3M) and compared the 
response to that of parental H7N3 and PH1N1 virus. The parental H7N3 virus induced 
significantly (P<0.05) higher concentrations of inflammatory mediators, such as IL-12(p40) 
early following inoculation (day 3) relative to PH1N1 (Table 2.1). Infection with H7N3PB2 
induced higher concentrations of key inflammatory mediators including CCL2, CCL3, and 
CCL5 relative to H7N3 (P<0.05). H7N3PA replication was attenuated in vivo and this virus 
correspondingly induced significantly lower levels of many inflammatory cytokines relative to 
H7N3 (P<0.05). By 7 days post infection, PH1N1 infected lungs had higher concentrations of 
cytokines relative to parental H7N3 while H7N3PB2 produced even more exacerbated responses 
in many mediators, including IL-10, CCL2, CCL3, CCL5, and TNF-α (P<0.05-P<0.001 relative 
to H7N3, Table 2.2). H7N3NA and H7N3M elicited inflammatory responses that more closely 
resemble the profile of H7N3 than PH1N1 at both time points following infection.  
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Table 2.1. Inflammatory cytokine and chemokine levels in total lung homogenates three 
days after intranasal inoculation with parental H7N3, PH1N1, and reassortant viruses.  
 Concentration (pg/ml) (mean ± S.E.M.) in mouse lung 
 Virus    
Cytokine 
 
H7N3WT 
 
H7N3PB2 
 
H7N3NA 
 
H7N3M 
 
PH1N1WT 
 
IL-1α 267 ± 5 32 ± 4 23 ± 6 33 ± 7 12 ± 5* 
IL-1β 360 ± 
 
436 ± 57 494 ± 73 498 ± 66 169 ± 22 
IL-5 294 ± 95 529 ± 56 423 ± 45 356 ± 58 29 ± 13* 
IL-6 228 ± 69 363 ± 78 451 ± 49* 288 ± 57 70 ± 30 
IL-10 21 ± 3 20 ± 2 16± 2 20 ± 2 13 ± 4 
IL-12p40 253 ± 63 421 ± 65 244 ± 36 383 ± 51 85 ± 24* 
IL-12p70 100 ± 27 48 ± 7 44 ± 8 55 ± 12 63 ± 36 
IL-13 52 ± 3 64 ± 5 45 ± 5# 48 ±5 26 ± 3& 
Eotaxin 462 ± 97 613 ± 24 732 ± 60* 570 ± 107 175 ± 25 
G-CSF 268 ± 78 579 ± 113* 336 ± 92 263 ± 22 249 ± 91 
GM-CSF 67 ± 11 65 ± 5 57 ± 6 50 ± 6 46 ± 13 
Interferon-γ 9 ± 1 20 ± 3& 7 ± 1 9 ± 3 5 ± 1* 
KC 370 ± 88 435 ± 119 456 ± 95 533 ± 52 151 ± 56 
CCL2 586 ± 
 
3145 ± 
 
1115 ± 84& 758 ± 99 835 ± 292 
CCL3 52 ± 16 125 ± 18* 77 ± 24 65 ± 21 22 ± 8 
CCL4 
 
72 ± 20 128 ± 34 84 ± 17 68 ± 6 44 ± 8 
CCL5 89 ± 13 148 ± 27* 125 ± 25 105 ± 31 66 ± 24 
TNF-α 172 ± 49 123 ± 12  126 ± 21 100 ± 9 262 ± 52 
(*, P < 0.05; #, P < 0.01; &, P < 0.005, compared to H7N3 values).   
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Table 2.2. Inflammatory cytokine and chemokine levels in total lung homogenates seven 
days after intranasal inoculation with parental H7N3, PH1N1, and reassortant viruses. 
 
 
Concentration (pg/ml) (mean ± S.E.M.) in mouse lung 
 Virus     
Cytokine 
 
H7N3WT  
 
H7N3PB2  
 
H7N3NA  
 
H7N3M   
 
PH1N1WT  
 
IL-1α 13 ± 1 48 ± 4& 22 ± 8 32 ± 2& 31 ± 2& 
IL-1β 313 ± 80 669 ± 77 337 ± 99 840 ± 51* 519 ± 112 
IL-5 131 ± 35 120 ± 23 313 ± 95 178 ± 36 235 ± 35 
IL-6 198 ± 39 148 ± 35 355 ± 105 183 ± 45 790 ± 85& 
IL-10 62 ± 6 247 ± 63* 76 ± 27 109 ± 16 123 ± 12# 
IL-12p40 328 ± 78 462 ± 66 218 ± 52 713 ± 122* 313 ± 39 
IL-12p70 44 ± 9 104 ± 24* 63 ± 10 37 ± 3 82 ± 14* 
IL-13 92 ± 14 248 ± 19& 92 ± 16 193 ± 10& 123 ± 44 
Eotaxin 1678 ± 
 
465 ± 89 464 ± 94 432 ± 88 393 ± 55 
G-CSF 288 ± 53 289 ± 87 333 ± 127 490 ± 141 
  
1362 ± 105& 
GM-CSF 46 ± 6 80 ± 7# 37 ± 3 105 ± 4& 152 ± 85 
Interferon-γ 46 ± 12 63 ± 27 24 ± 18 51 ± 1 276 ± 96* 
KC 196 ± 65 351 ± 54 284 ± 130 153 ± 59 338 ± 80 
CCL2 750 ± 25 2580 ±610* 402 ± 198 201 ± 114* 2273 ± 288&             
CCL3 172 ± 18 2544 ± 610# 96 ± 35 737 ± 243 692 ± 171* 
CCL4 196 ± 41 156 ± 35 99 ± 63 69 ± 13* 110 ± 20 
CCL5 692 ± 78 1672 ±333* 271 ± 193 593 ± 116 294 ± 65# 
TNF-α 161 ± 27 478 ± 99* 221 ± 44 167 
  
307 ± 35# 
(*, P < 0.05; #, P < 0.01; &, P < 0.005, compared to H7N3 values). 
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2.6 Discussion 
The ongoing reassortment of avian and human IAV threatens human populations 
worldwide as evidenced by numerous recent zoonotic events 21. Along with H5- and- H9 
subtypes, H7-subtype viruses are thought to be candidates for generating a pandemic IAV. We 
sought to determine the potential for reassortment between a low-pathogenic North American 
avian H7N3 virus and diverse avian and mammalian virus isolates.  Our studies identified a clear 
bias towards reassortment of H7N3 with gene-segments derived from the 2009 pandemic H1N1 
(PH1N1) virus, but not other mammalian virus isolates. We found that single reassortant H7N3 
viruses containing PB2, NA, or M segments of PH1N1 do not attenuate the H7N3 virus in vitro 
or in vivo. Our results highlight the potential for environmental reassortment that can lead to 
antigenically novel viruses capable of inducing disease in mammals and may inform future 
surveillance efforts. Moreover, these findings support the potential for emergence of future pre-
pandemic viruses in avian populations without prior mammalian adaptation. 
We used a novel plasmid-based genetic screen to assess the compatibility of human and 
avian genome segments in the context of a low-pathogenic North American H7N3 virus. We 
found that PH1N1 genome segments were selected most frequently among mammalian derived 
segments, suggesting a high degree of functional compatibility of these segments with the H7N3 
virus when compared to pre-pandemic human isolates. We found no instances of seasonal H1N1 
(SH1N1) gene segments reassorting with the avian virus and only seldom observed inclusion of 
genes from the PR8H1N1 strain. This striking difference suggests that the current H1N1 virus 
(PH1N1) is more likely to reassort with other viruses and create novel pandemic viruses. While 
the mechanism underlying this preference is unknown, it is plausible that the extended adaptation 
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of gene-segments of SH1N1 to the human host and other segments of SH1N1 has decreased its 
ability to reassort with avian or other human viruses. In contrast, gene-segments of PH1N1 are 
found in many different virus isolates validating the ability to reassort rapidly with other strains 
of influenza virus.  
We observed a high frequency of H7N3 and H7N9 segment selection in instances when 
these segments were closely related (Figure 2.1 B). However, in not all instances did high 
nucleotide similarity to the parental H7N3 segment result in high rates of selection, for example 
the M and NA segments of PH1N1 virus. This discrepancy perhaps indicates, that within this 
system, compatibility between proteins, not genome segments, drives viral replication and 
therefore selection. 
Historically, reassortment of influenza viruses was studied using co-infection models. 
These experiments provided important information about the natural evolution of IAV; however, 
they are less controlled and potentially more hazardous if one or both IAVs have previously been 
shown to transmit between mammals. We provide an alternative method to study influenza 
reassortment and argue that these experiments are not only safer, but also address a different 
question and that is; what are the molecular requirements of a single gene-segment to compete 
with and reassort into an existing virus genome? Knowing the key features in a genome segment 
that promotes or inhibits reassortment will result in a better understanding of the process as a 
whole and therefore improve our predictions on the outcome of experimental and natural co-
infections.  
These studies identified two pandemic IAV gene segments, NA and M, which in the 
context of H7N3 virus do not impact viral replication in MDCK cells or pathogenesis in mice. 
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The compatibility of these genes with H7N3 is of interest given their prior association with 
increased transmission of the 2009 pandemic H1N1 when compared with putative pandemic 
progenitors 22. Multiple independent reassortment events between human and swine influenza 
viruses resulted in the creation of novel genome constellations (H1N1v, H2N1v, and H3N2v) 
capable of aerosol transmission from pig to human due to acquisition of PH1N1 M.  Previous 
investigations of potential reassortant viruses between a highly pathogenic avian H5N1 influenza 
virus and PH1N1 demonstrated high compatibility between H5N1 and the NA and M segments of 
PH1N1 23. The resulting reassortant viruses similarly did not have altered in vitro replication 
relative to wild-type H5N1 virus. To further experimentally corroborate the importance of this 
segment in PH1N1 transmission, multiple studies engineered reassortant viruses that either 
gained or lost the ability to transmit between mammals following manipulation of M 22,24. In 
combination with M, NA was capable of enhancing the transmission of PH1N1 through altered 
receptor destroying activity (NA) and filamentous particle morphology (M) that changes virus 
release from the respiratory tract of infected animals compared to diverse contemporary swine 
isolates. Although our studies did not examine virion morphology or respiratory shedding, 
additional studies in a model more suitable for examining such phenotypes may provide insights 
into the activity of these genes in the genetic background of an avian influenza virus.  
The potential for transmission of H7-bearing viruses has been demonstrated 
experimentally 25. Since other North American H7-HA are able to bind both avian and 
mammalian receptors, additional adaptations or acquisition of other gene segments via 
reassortment may be critical to achieve sustained mammalian transmission 26–28. Other avian viral 
subtypes (i.e. H9N2 and H5N1) can reassort with PH1N1 and achieve contact or respiratory 
droplet transmission 2,4,16. Additionally, reassortant viruses possessing PH1N1 M are capable of 
 55 
directly infecting humans from pigs 29. Our studies show H7N3 viruses possessing PB2, NA, or 
M from PH1N1 are not attenuated in vivo and induce disease comparable to wild type H7N3 
without adaptation. Further studies of these viruses and other similar single reassortant avian 
viruses in mammalian transmission models are required to understand the constellation of 
reassortants that are potential sources of new zoonoses. 
PB2 is the only PH1N1 gene segment that increased the virulence and replication in vivo 
relative to wild type H7N3 despite attenuation in vitro. Previous studies have identified several 
amino-acid substitutions that are associated with efficient replication in mammalian cells, 
including G590S, Q591R, E627K, and D701N 30–32. The PB2 of H7N3 virus contains all avian residues, 
while the PB2 of PH1N1 has the G590S and Q591R substitution. Based on this information, we 
anticipated that the PB2 of PH1N1 would increase replication of the H7N3 7+1 virus in 
mammalian cells. As increased viral replication may exacerbate initial inflammatory responses 
and lead to subsequent morbidity 18,20, we assessed the abundance of cytokines and chemokines 
present in whole lung homogenate at two points following infection (Tables 2.1 and 2.2). 
Mammalian adapted PH1N1 PB2 increased induction of pro-inflammatory cytokines IL-6, CCL2 
and CCL3 early during infection (day 3, Table 2.1). CCL2 levels also correlated well with 
morbidity when assessed later during infection at 7 dpi, likely due to increased viral replication 
early following inoculation (Table 2.2). Importantly, while morbidity and viral titer were 
increased relative to parental H7N3, substitution of PH1N1 PB2 did not induce morbidity 
equivalent to parental PH1N1 at low inoculum dose.  
While most H7N3 7+1 reassortant viruses did not contain mutations in the PH1N1 gene-
segment, we repeatedly recovered H7N3PA virus containing an amino acid substitution at position 
295 (P295L). In a unique isolate from the 2009 pandemic – A/Tennessee/560/09 (H1N1)- mouse 
 56 
adaptation introduced the inverse mutation PA L295P 33. Upon further examination, creation of a 
virus with only this mutation led to increased viral replication in normal human bronchial 
epithelial (NHBE) cells. In a different study, the same group described L295P as contributing to 
increased and prolonged viral shedding and disease in both donor and contact ferrets34. 
Additionally, the same polymerase assay that we utilized, A/Tennessee/560/09 PA L295P 
increased reporter activity in the context of other A/Tennessee/560/09 proteins and the co-
expressed level of PB2 but not of NP 33. The importance of this residue had not to our knowledge 
been examined in the context of A/California/04/09 PA before this report, though it may be 
surmised that the P295L mutation is detrimental to the PA function in the mammalian host and 
perhaps was selected for due to interaction with the avian host during growth in chicken eggs or 
with a component of the H7N3 polymerase complex.  
In the context of the H7N3 polymerase complex, this mutation reduced the polymerase 
activity 2-fold (Figure 2.3). At this time we cannot address if the observed differences in 
polymerase activity are due to altered protein half-life, expression level, or inherent enzymatic 
activity of PH1N1 PA in either H7N3 or PH1N1 complexes. It is not known if this mutation 
affected the virulence of H7N3PA in mice, but based on published data we expect that an H7N3 
virus containing the wild-type PA of PH1N1 is even more attenuated. 
Taking the data together, we establish that the 2009 pandemic H1N1 has a high degree of 
compatibility with a North American LPAI H7N3 virus. Further, the genome segment reassortant 
viruses containing the PH1N1 segments most frequently selected (PB2, NA, or M) establish 
productive infection in the mouse respiratory tract, induce morbidity and disease, and persist for 
at least one week, potentially allowing dissemination to others by contact or respiratory 
transmission. Future studies may examine the potential for transmission of these H7 viruses 
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containing single genes from 2009 pandemic H1N1. These studies emphasize the need for 
continued surveillance of the avian IAV reservoir and the critical importance of identifying 
reassortant viruses that contain genomic signatures associated with mammalian disease and 
transmission.  
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Figure 2.1.  A North American H7N3 virus preferentially selects avian and 2009 
pandemic H1N1 genome segments following competitive transfection.  
A. Seven genome segments derived from A/shorebird/Delaware/22/2006 (H7N3) were co-
transfected with four (NA only) or five variants of the eighth genome segment. These variants 
included the homologous gene-segment from A/shorebird/Delaware/22/2006 (H7N3) as well as 
that of A/mallard/Alberta/177/2004 (H7N9), A/Memphis/03/2008 (SH1N1), 
A/California/04/2009 (PH1N1), and A/Puerto Rico/08/1934 (PR8H1N1) virus. Following 
transfection, individual virus particles were cultured in MDCK cells using a limiting dilution 
assay. Virus positive wells were identified by HA assay and the remaining supernatant was used 
to purify viral RNA. cDNA was generated using a universal influenza primer and the segment of 
interest was amplified using segment-specific PCR primers and analyzed by restriction length 
fragment polymorphism (RFLP). B. Pie charts depicting the relative distribution of four or five 
gene-segments that were identified among the competitive reverse genetics derived H7 viruses. 
The results are the cumulative distribution of two or more independently repeated experiments; 
334 viruses in total sampled. The NA gene of A/Memphis/03/2008 (NA-inhibitor insensitive) 
was excluded from these analyses. Phylogenetic trees for each corresponding segment 
illustrating the genetic relationship to between segments assayed (bootstrapped 1000x). The line 
beneath each phylogenetic tree represents 1 nucleotide substitution per 100 nucleotides.  
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Figure 2.2. Several H7-single gene reassortant viruses possessing a PH1N1 segment 
replicate to efficiently in mammalian tissue culture.  
MDCK cells were inoculated with 50 TCID50 of the indicated virus and virus titer (TCID50/ml) in 
the supernatant was determined at 24 (A) or 48 (B) hours post- inoculation by virus titration 
assay on MDCK cells. A549 cells were inoculated with 105 TCID50 of the indicated virus and 
virus titer (TCID50/ml) in the supernatant was determined at 24 (C) or 48 (D) hours post-
inoculation by virus titration assay on MDCK cells. The limit of detection was 100 TCID50 
(dotted line). The data represent the geometric mean + the standard error of the mean of four 
samples derived from two or three independent experiments performed in duplicate (*, P<0.05; 
**, P<0.01; ***, P<0.005, compared to H7N3 values). 
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Figure 2.3. PA protein from pandemic H1N1 virus increases polymerase activity of 
H7N3 in human 293T cells. 
A. A reporter assay was used to measure the relative polymerase activity of different polymerase 
protein complex combinations between H7N3 and PH1N1 viruses, including PH1N1 PA P295L as 
described in the Materials and Methods. The relative polymerase activity was first normalized to 
the Renilla activity and compared to that of a full set of H7N3 polymerase proteins. Blue boxes 
represent H7N3 proteins, white boxes represent pH1N1 proteins, and spotted white boxes 
represent pH1N1 PA-P295L. Data represent the average normalized value from three or five 
experiments performed in duplicate (*, P < 0.05; **, P < 0.01; ***, P < 0.005, compared to 
H7N3 values).  
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Figure 2.4. Reassortant H7 viruses containing PH1N1 PB2, NA, or M induce 
considerable morbidity in mice 
(A-C). Groups of male C57BL/6J were inoculated intranasally with 104 TCID50 of the indicated 
viruses and weight loss was measured for 7 days. Morbidity is displayed as percent of original 
body weight remaining for mice inoculated with the indicated virus that showed significantly 
greater (A), equal (B), or significantly less (C) weight loss than the parental H7N3 virus. (D) 
Male C57BL/6J mice were inoculated intranasally with 103 TCID50 of H7N3, PH1N1 or H7N3 
containing the PB2 of PH1N1 (H7N3PB2) and weight loss was measured for 14 days. The data 
represents the average and standard error of the mean of at least six animals from two or more 
independently performed experiments per virus. (*, P < 0.05; **, P < 0.01; ***, P < 0.005, 
compared to H7N3 values; #, P < 0.05; ##, P < 0.01; ###, P < 0.005; ####, P < 0.001, 
compared to PH1N1 values). 
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Figure 2.5. H7N3 replicates extensively in the lungs of C57BL/6J mice and PH1N1 PB2, 
NA, or M do not attenuate H7N3. 
Male C57BL/6J mice were inoculated with 104 TCID50 of H7N3, PH1N1, or the indicated 
reassortant virus and lung viral titers were quantified 3 and 7 days post inoculation. Virus titer 
present in whole lung homogenate at day 3 (A) or day 7 (B) was determined by virus titration 
assay on MDCK cells and expressed as TCID50/ml.  Viral titers were derived from five or more 
mice from two or more independently performed experiments. The limit of detection was 100 
TCID50 (dotted line). (*, P < 0.05; **, P < 0.01; ***, P < 0.005, compared to H7N3 values.)  
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Chapter 3: 
Amino Acid Identity Affects Competitive 
Incorporation of influenza A Genome 
Segments and Limits the Potential for 
Reassortment 
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3.1 Abstract 
Influenza A virus (IAV) reassortment leads to the generation of new viral strains 
including those with pandemic potential. The segmented nature of the viral genome allows co-
packaging of viral genomic RNA from multiple parental strains upon cellular co-infection. 
Previous studies have identified so-called packaging signals at the distal ends of each vRNA 
segment as determinants of selective packaging of reporter RNAs into viral particles. More 
recently vRNA bundling signals and other structural sequence elements that lie outside of these 
canonical packaging elements were implicated in the selection of divergent RNA species. Here 
we utilize a recently developed competitive reverse genetics strategy to comprehensively assess 
the potential for reassortment between genetically diverse virus segments in the context of an 
isogenic background commonly used in laboratory and vaccine development settings. Initially, 
we show that competition occurs in vitro in a genome context-dependent manner. We then 
determine the n-terminal region outside of known packaging elements of segment 3 (PA) is a 
determinant of selection. These experiments simultaneously reveal inherent flexibility of the 
viral genome while illuminating sequences that are important for selective packaging during co-
infection. Finally, we examine the nucleotide and amino acid identities within segment 3 that 
drive the preferential selection of one strain’s segment over another. Taken together we establish 
the amino acid identity of PA-184, as an important human-specific determinant of polymerase 
activity and competitive selection in this system.  
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3.2 Introduction 
Influenza A viruses (IAV) belong to the orthomyxovirus family. These viruses possess a 
genome composed of eight single-stranded negative-sense RNA segments encapsulated in a 
nucleoprotein coat and polymerase complex packaged in a host-cell derived envelope1. In the 
event of cellular coinfection, viral ribonucleoprotein complexes (vRNPs) from multiple strains of 
the virus are able to simultaneously utilize the host cell for replication and genome packaging2. If 
a mixed genome is successfully packaged, resulting viruses with segments from both parental 
strains result - giving rise to a new genome constellation3. This process, termed reassortment, is 
one of the evolutionary strategies employed by IAV to produce new viral strains that may have 
altered replication, pathogenesis, and transmission profiles when compared to previous isolates. 
For reassortment to be successful new genomic constellations must be replication competent and 
when there is little difference between constituent segments of two viruses reassortment may 
occur at a high frequency2. Importantly, reassortment may result in progeny viruses with mixed 
genomes that possess a combination of virologic traits that induce shifts in host adaptation, 
transmission potential, and pathogenesis4.  
Influenza reassortment has lead to the generation of multiple viruses capable of 
generating pandemics. Requisite for pandemic formation is the ability of the virus to break 
animal-to-human transmission barriers, replicate and release efficiently in the human host, and 
transmit form human-to-human. The profound effect of reassortment may be illustrated by 
inspecting the phylogeny of pandemic IAVs from 1918 to 2009 and the recently emergent 
H7N95.  In each case an antigenically distinct HA was acquired by way of reassortment with a 
virus capable of transmitting to and replicating in humans. Humoral immunity to HA is the 
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primary basis of current vaccination strategies and antigenic shift of HA by reassortment alters 
recognition by antibodies6. The 1918 H1N1 "Spanish Flu" was likely created by reassortment of 
at least one avian virus and a mammalian virus that circulated in porcine hosts before 
introduction to humans7. Between 20-50 million people died as a result of primary influenza 
infection and subsequent secondary pneumonia. Contemporary segments with high homology to 
the 1918 H1N1 strain persist in both avian and swine populations8. Experimental creation of an 
H1N1 strain derived from currently circulating avian genome segments was also shown to cause 
severe disease in mammals and can transmit between ferrets9. Moreover, reassortment between 
human and avian influenza A viruses, likely in a porcine vessel, resulted in the generation of 
H2N2 and H3N2 strains that caused pandemics in 1957 and 1968, respectively. H3N2 viruses 
have continued to circulate following the pandemic and are, along with H1N1, the primary cause 
of seasonal epidemics7,10.  
Prior to each pandemic, antigenic shift of external proteins occurred in addition to 
transfer of internal gene segments. The 2009 pandemic H1N1 emerged following at least three 
independent reassortment events involving human, porcine, and avian viruses. In each recent 
human pandemic the PB2 and PA segments co-segregated in part due to a requirement for 
interacting viral protein interfaces. Co-segregation of H3N2 and H1N1 PB2 and PA segments 
has been demonstrated experimentally using high-content reassortment assays with replicating 
viruses11. Additionally, the interdependence of PB2 and PA residues has been interrogated 
extensively in vitro utilizing co-transfection mini-genome assays to assess the amino acid 
residues responsible for polymerase complex activity in the context of reassortant protein 
complexes. Utilizing phylogenetic data from human and avian strains, interdependence on amino 
acid residues 184 and 383 in the PA subunit were required for an H1N1 PA to be able to 
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replicate genome in the context of a polymerase complex otherwise derived from an H3N2 
isolate12. 
Here, we utilize a competitive reverse genetics system to identify differences genetic 
restriction of closely related avian gene segments in the context of a H1N1 virus in human 
cells13. We identify specific polymerase complex combinations in the context of replicating virus 
and map this activity to a specific genetic locus in PA14. Prior studies have focused on the 
restriction of reassortment between H3N2 and H1N1 viruses, whereas we explore why certain 
otherwise functional avian genes are non-permissively excluded from H1N1 viruses during 
competition. We find, that the identity of amino acid 184 dictates the ability of an avian H7N3 
PA genome segment to be incorporated into a H1N1 isolate descended from the 1918 pandemic 
H1N1. Additionally, the selection bias demonstrated during reverse genetic competition assays 
may be alleviated by addition of the heterologous H7N3 PB2 segment, indicating a specific 
interplay between these two elements. Manipulation of the H1N1 PA-184 residue attenuated 
virus replication in human, but not canine cells and this can be attributed to diminished 
polymerase activity. Restoration of the H1N1-like PA-184 residue increases the polymerase 
activity of H7N3 PA and relative competitive incorporation rate when compared to the H1N1 
virus, indicating that this amino acid is a species-specific and context-dependent regulator of 
reassortment potential. 
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3.3 Materials and methods 
Biosafety Considerations 
All reverse genetic experiments were carried out in the BSL2+ setting, within a class II 
biosafety hood, utilizing appropriate personal protective equipment. All experiments were 
discussed with Washington University in Saint Louis’s Institutional Biosafety Committee (IBC) 
and approved by the biosafety officer.  
Viruses 
Viruses used in this study: A/shorebird/Delaware/22/2006 (H7N3), A/California/04/2009 
(PH1N1), A/mallard/Alberta/144/2007 (H7N9), A/Memphis/03/2008 (SH1N1), and A/Puerto 
Rico/08/1934 (PR8H1N1). For SH1N1, H7N3, and H7N9, cDNA for all gene segments was cloned 
into the bi-directional pHW2000 plasmid and used to generate influenza viruses as previously 
described (see Chapter 2). Dr. Richard Webby at St. Jude Children’s Research Hospital kindly 
provided the reverse genetic plasmids for PH1N1 and PR8H1N1. Plasmid-derived A/Puerto 
Rico/08/1934 (H1N1), A/shorebird/Delaware/22/2006 (H7N3), and all PR8H1N1 7+1 single 
reassortant viruses, were generated using the 293T-Madin-Darby canine kidney cell (MDCK) co-
culture system and supernatant was injected into 10-day old embryonated chicken eggs for 48 
hours at 35°C (Cackle Hatcheries, IA, USA). Allantoic fluid containing the infectious virus was 
harvested and stored at -80°C. The viral titer (tissue culture infectious dose 50, TCID50) was 
determined using MDCK cells and viral stock used in this study was titrated at least twice 
independently. Single reassortant viruses on the background of PR8H1N1 possessing a single 
genome segment from H7N3 used in this study have been named with the following convention 
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– seven segments from the PR8H1N1virus plus the substituted H7N3 segment in subscript (ex. 
PR8:PAH7N3). 
 Cells 
MDCK cells were maintained in Minimal essential medium (MEM) with 5% Fetal 
bovine serum (FBS), vitamins, L-glutamine (Invitrogen), penicillin, and streptomycin. 293T cells 
were maintained in Opti-MEM with 10% FBS, L-glutamine, penicillin and streptomycin. A549 
cells were maintained in Dulbecco’s Minimal essential medium (DMEM) with 10% FBS 
vitamins, L-glutamine, penicillin, streptomycin, 25mm HEPES, and non-essential amino acids 
(NEAA). 
Competitive Reverse Genetic Assay  
We utilized a previously developed competitive reverse genetic assay to evaluate the 
ability of avian and human IAV genome segments to reassort in the context of a PR8H1N1 viral 
background (Figure 1A). 293T-MDCK co-cultures were transfected with pHW2000 plasmids (1 
µg per segment) containing seven genome segments of PR8H1N1 virus plus four (for NA segment 
due to exclusion of NA from sH1N1) or five plasmids encoding a single genome segment (e.g. 
PB2) from different avian and human influenza viruses. All transfections included the wild-type 
PR8H1N1 segment in addition to those from divergent strains. We did not evaluate the HA 
genome segment because of biosafety considerations. The total amount of co-transfected plasmid 
DNA for the 8th segment (1 µg) was divided equally between the four or five studied viruses 
including the parental strain. The DNA was mixed at a 1:2 ratio with Trans-IT LT1 (Mirus) in 
Opti-MEM for 20 minutes at room temperature and added to the culture medium. Following an 
overnight incubation, the cell culture medium was removed and 1ml of fresh Opti-MEM 
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supplemented with penicillin, streptomycin, L-glutamine was added. Twenty-four hours later an 
additional 1ml of Opti-Mem with 1μg/ml TPCK-trypsin (Worthington) was added. Forty-eight 
hours later supernatants were collected, cell debris removed by centrifugation at 1,200xg, and 
frozen at -80°C until further analysis. Clonal viral populations were isolated by limiting dilution 
assay on MDCK cells, then viral RNA extracted, reverse-transcribed using a vRNA-specific 
primer, and amplified with segment-specific PCR primers. Genome segment amplicons were 
genotyped by either restriction fragment length polymorphism analysis (RFLP) or Sanger 
sequencing. RFLP analysis was performed with one to four different restriction enzymes 
yielding a unique fragment length pattern for each segment and strain: PB2 (EcoRI, HindIII, 
BamHI); PB1 (HindIII); PA (BamHI, HindIII, XbaI); NP (BamHI, BglII); NA (BamHI, BglII, 
EcoRI, BsmBI); M (BamHI, HindIII, XcmI, PvuII). All restriction enzymes were obtained from 
New England Biolabs and used according to their instructions. The NS gene segment was 
genotyped by Sanger sequencing.  Competitive reverse genetic assays were completed at least 
twice independently for each genome segment.  
Multistep Growth Curves of Influenza A virus 
2x105 MDCK cells were seeded in 24-well plates and infected the next day at MOI 0.001. 
Briefly, MDCK cells were washed once with PBS before adding the inoculum in Minimal 
Essential Medium (MEM) containing penicillin, streptomycin, glutamine, and vitamins plus 
0.1% bovine serum albumin (M0.1B) for one hour at 37°C. After the one hour, the cells were 
washed with PBS and 1.0 ml of M0.1B with 1µg/ml TPCK-trypsin (Worthington Technologies) 
was added to each well. Culture supernatants were collected at 24 and 48 post infection and the 
amount of infectious virus was quantified by titration on MDCK cells. All growth curve 
experiments were performed at least twice in duplicate. Infection of 293T cells was performed in 
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24-well plates coated with poly-D-lysine to enhance cellular adherence with each well containing 
2x105 cells. Infection of cells was performed at MOI 0.1 and samples collected from supernatant 
at 24 hours. One hour post-infection, inoculum was removed, cells washed once with PBS, and 
fresh M0.1B media containing 0.4 µg/ml TPCK-trypsin was added to the culture. 
Generation of mutants 
 Chimeric segments were generated by creation of fragments that carried BsmBI (New 
England Biosciences) restriction sites to allow scar-less integration of unique pieces. All single-
mutant pHW2000 plasmids were generated by use of the Agilent Quick Change II system 
according to the manufacturer’s protocol. Sequence identity of all newly generated chimeric and 
mutant plasmids was verified by sequencing. All viruses were additionally examined for rescue 
capacity in the PR8H1N1 background and successfully generated. 
Mini-genome luciferase assay with polymerase genes of influenza A virus 
The PB2, PB1, PA and NP genes from PR8H1N1 and H7N3 were previously cloned into the 
pHW2000 vector. The pLuci plasmid was kindly provided by Dr. Yen (Hong Kong University, 
Hong Kong, China) and contains the firefly luciferase gene flanked by the non-coding regions of 
NP gene segment in the negative orientation. The transcription of this influenza A virus-like 
gene segment is under the control of a human polymerase I promoter. A Renilla luciferase gene 
containing expression plasmid is used to normalize for transfection efficiency. 293T cells are 
transfected with plasmids containing the PB2, PB1, PA and NP gene segments of IAV plus the 
two luciferase containing plasmids (500ng total DNA) using TransIT LT1 (Mirus Bio LLC). The 
next day the media was changed and the assay was incubated for 48 hours from the time of 
transfection before the cells were harvested, lysed and used to analyze Firefly and Renilla 
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luciferase activity (Promega). Each condition (set of plasmids) was done in duplicate and 
repeated independently in separate experiments three times. The relative light units (RLU) of 
firefly are normalized to the RLU for Renilla and the activity of varying polymerase 
combinations are then normalized to that of the full complement of PR8H1N1 IAV segments 
within each experiment.   
TCID50 assay 
Confluent monolayers of MDCK cells were grown overnight in 96-well plates. The next 
day, the cells were washed with PBS and inoculated with ten-fold serial dilutions (10-1 to 10-8) of 
culture supernatant, allantoic fluid or lung homogenate for one hour in M0.1B at 37°C and 5% 
CO2. After one hour the inoculum was removed and replaced with M0.1B supplemented with 
1µg/ml TPCK-trypsin and incubated for 72 hours. Presence of virus was determined by 
hemagglutination assay using 0.5% turkey red blood cells. TCID50 was determined by the Reed-
Muench method 15. 
Inoculation of embryonated eggs with influenza A virus 
 Embryonated hen eggs from Cackle Hatcheries, Iowa, USA, were inoculated with the 
indicated dose of virus in 100uL sterile PBS and 1X egg antibiotics (I need to include these 
specifically probably) by needle injection of the allantois cavity. Eggs were incubated at 35°C 
for 48 hours, and then chilled overnight. The following day allantois fluid was harvested, cleared 
of debris by centrifugation at 1,200 RPM for 5 minutes, stored at -80°C for analysis.  
RT-qPCR analysis  
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For all experiments 100uL of viral supernatant was harvested in 275uL lysis buffer and 
stored at -80C until use. RNA was extracted using the Omega E.Z.N.A. Total RNA I Kit 
according to the manufacturer’s instructions and eluted in 50uL RNase-Free Water. 2μL of 
total RNA was reverse transcribed with random hexamers using SuperScript III reverse 
transcriptase (Invitrogen) according to manufacturer’s instructions. After diluting cDNA 1:10 in 
H2O, 4μL was added to a mixture of the indicated primer-probe (IDT), H2O and 10μL of 2x 
qPCR MasterMix (TaqMan® Fast Universal PCR Master Mix (2x) Applied Biosystems by Life 
Technologies). All qPCR assays were performed using the 7500 Fast system. Cycle-threshold 
values were uniformly set to 0.4.  
Statistical analysis 
Statistical analyses were performed using GraphPad Prism 6.0 software. All statistical 
comparisons were performed using One-Way ANOVA with Dunnet’s Correction for multiple 
comparisons or Two-Way ANOVA with Sidak Correction for multiple comparisons as indicated 
in figure legends. 
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3.4 Results 
Competitive reverse genetics reveals inherent biases during conditions mimicking 
reassortment.  
Influenza A virus possesses a segmented RNA genome; as such the coordinated 
packaging of each segment must be maintained for progeny virus formation. Each genome 
segment must be packaged into newly forming virions to allow replicative success following 
egress from the host cell. To assess the potential for reassortment between viruses and 
interrogate viral features that dictate selection of a given segment in a competitive context, we 
utilized an established in vitro reassortment system. In this system, utilizing an isogenic viral 
background, we have identified inherent biases in the creation of reverse genetic derived IAV. 
We chose to examine competitive incorporation in the context a common laboratory strain 
A/Puerto Rico/08/1934 (H1N1) (PR8H1N1) and compared the results to those we determined 
previously for an avian isolate A/shorebird/DE/22/2006 (H7N3) - to examine if the determinants 
of reassortment are strain specific. Additionally, we included segments from another avian 
isolate – A/mallard/Alberta/144/2007 (H7N9) –and two human strains – A/Memphis/03/2008 
(H1N1) (SH1N1) and A/California/04/2009 (H1N1) (PH1N1). In our competitive reverse genetics 
system, seven segments are held constant as a stable backbone while five options of the eighth 
segment are provided in equal amounts (Figure 3.1 A). The same technique is utilized to 
generate wild type and reassortant viruses utilized in later studies. Following a period of 
infection the supernatant is harvested, titered, and subjected to a limiting dilution assay to isolate 
clonal viruses. Next, individual viruses are isolated, RNA extracted, reverse transcribed, 
amplified with segment specific primers and identified by restriction fragment length 
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polymorphisms or Sanger Sequencing (Figure 3.1 B). We have assessed the incorporation rate 
of Segments 1-3 and 5-8 in at least two independent experiments. Segment 4 (HA) was excluded 
from this study due to biosafety concerns. 
PR8H1N1 preferentially packages human-derived genome segments 
We found repeatedly that the PR8H1N1 background preferentially incorporated segments 
derived from human isolates compared to avian origin segments in all cases. More heterogeneity 
in resulting viral pools was observed when PA, M, and NS were assessed. We additionally chose 
to determine the rescue efficiency of all possible single gene reassortants that may be created 
under these conditions. We were able to efficiently recover 22 of 28 viruses to levels within 10-
fold of the parental PR8H1N1 background (Figure 3.1 B). Only six single reassortant viruses were 
not generated after multiple attempts, interestingly including the avian-origin PB2 segments, and 
intriguingly the human origin PA segments. Additionally, although we did not assess the 
competitive outcomes of Segment 4 (HA) we were able to recover virus representing each of 
these as well. We then chose to focus on the genes that comprise the vRNP and polymerase 
complexes, as compatibility of proteins derived from these segments have been identified as 
primary host restriction factors following reassortment in previous studies.  
Preferential Incorporation of Segment 3 (PA) is due replication kinetics in human cells. 
We chose to focus on the selection differences of Segment 3 (PA) because of the genetic 
interaction of PA and PB2 observed in nature11,12. Prior studies on co-functionality of these 
segments identified residues required for function of a H1N1 PA in the context of a H3N2 
polymerase complex12. We wondered if similar genetic features determined the differential 
incorporation of closely related avian Segment 3 segments in a H1N1 context (Figure 3.1 A). In 
 87 
head-to-head competitive transfections in the PR8H1N1 background between the H7N3 and 
PR8H1N1 segments, only the PR8H1N1 segment was selected (Figure 3.2 A). Conversely, in the 
H7N3 context, only H7N3 PA was ever recovered when assessed by limiting dilution assay. We 
generated egg-derived stocks of PR8H1N1 and PR8H1N1 7+1 H7N3PA viruses and performed multi-
cycle replication studies at low multiplicity of infection and surprisingly found no difference in 
MDCK cells (Figure 3.2 B).  Next, we hypothesized there may be differences in coordinated 
genome packaging efficiency of these two viruses and utilized a particle-normalized single-step 
growth curve to assess the replication efficiency of these viruses in multiple cell types. 
Specifically, we included two human cell lines commonly utilized to study influenza viruses. 
A549 cells are a human adenocarcinoma cell line that is capable of supporting multi-cycle 
replication of IAV. 293T cells are utilized for transfection-based assays, including generation of 
reverse genetically-derived IAV, and assessment of IAV polymerase function. As such, we 
assessed the virus released from cells infected with equal particle number at 24 hours, in a 
single-round infection. As in the low MOI infection in MDCK cells we saw no replication defect 
of the PR8H1N1 7+1 H7N3PA relative to PR8H1N1 (Figure 3.2 C). Surprisingly, we saw a multi-log 
difference in replication in both human cell lines for PR8H1N1 7+1 H7N3PA relative to PR8H1N1, 
indicating a human-specific blockade of replication of a virus containing only one avian-origin 
genome segment. Similarly, we saw a decrease in the production of viral antigen in human, but 
not canine cells for H7N3PA relative to PR8H1N1 (Figure 3.2 D). 
Identification of Segment 3’s N-terminal region, independent of packaging signals, as a 
determinant of selection.   
We designed a strain-specific RT-qPCR assay to determine the relative abundance of 
viruses in supernatant following transfection and a single blind passage in MDCK cells to 
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amplify signal, since there are no replication differences in these cells. We found a greater than 
25-fold increase in H1N1PA relative to H7N3PA  in the PR8H1N1 context and the opposite in the 
H7N3 genomic context (Figure 3.3 A). 
The terminal regions of vRNA have been identified as determinants of segment 
packaging. Nearly a decade ago the identity of numerous synonymous mutations in these UTR 
and at the termini of the open reading frames (ORFs) of each segment were shown to impact the 
selection of artificial reporter segments encoding the ORF of fluorescent proteins16,17. Increasing 
recent evidence points to the central region of genome segments that were not assessed in early 
studies as additional critical determinants of selection during competitive conditions between 
divergent viruses18,19. To interrogate the contributions of naturally occurring nucleotide variation 
across the entire length of the segment we constructed chimeric segments that encode the 
packaging region of either PR8H1N1 and the central region of H7N3 or vice versa (Figure 3.3 B). 
Additionally, we constructed segments that mimic the boundaries of defective interfering RNAs 
that are able to be packaged and propagate during high multiplicity infection, but lack that ability 
to produce protein and replicate independently20. We find that in competition with a wild-type 
segment bearing the same packaging signals or with the extended DI boundary constructs, that 
the central region of the segment is a predominant determinant of segment 3 selection (Figure 
3.3 A).   
Having excluded traditional packaging signals, we explored whether or not the function 
of the polymerase complex in 293T cells was correlated with discrepant genome selection. We 
find that in the context of the PR8H1N1 polymerase complex H7N3PA is attenuated (Figure 3.3 
C). Additionally, the central region of the genome segment is responsible for this defect, as the 
packaging signals of DI-like constructs show no difference from the segment in which the central 
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region was derived (Figure 3.3 C). To further probe the region necessary for altered polymerase 
activity created additional constructs encoding the N- or C-terminus of either strain fused to the 
N- or C-terminus of the other strain and a majority H7N3 construct containing only nucleotides 
400-700 of PR8H1N1 (Figure 3.3 B). We found that the N-terminal region of PR8 (8N3C 
construct), located between nucleotides 400-700 (840037008 construct) is sufficient to increase 
H7N3PA polymerase function to greater than that of WT-PR8H1N1PA in the context of the 
remaining PR8H1N1 genome segments (Figure 3.3 C). Together these findings indicate the 
central region of Segment 3, between the boundaries of terminal packaging signals, but within 
the N-terminal half of the segment likely determines competitive selection.  
PA amino acid 184, but not 190, is a context-dependent determinant of differential segment 
selection 
Having established the central region of segment 3 as the primary segment-intrinsic 
driver of selection in this given background, and nucleotides 400-700 as the determinant of 
polymerase activity in human cells, we sought to utilize sequence analysis between the three 
strains that propagated equivalently but showed divergent selection properties (PR8H1N1, H7N3, 
and H7N9).  PA of H7N3 and H7N9 contain seven coding changes14. We have previously 
investigated the contribution of differences between these viruses as critical to regulation of virus 
replication and pathogenesis. H7N3 segment 3 was selected at a much lower rate than that of 
H7N9 in the context of a PR8H1N1 genome. As such we generated mutant segments bearing 
single amino acid changes at three positions that differed most in their biochemical properties 
and assessed the contribution of these amino acids to the polymerase activity and competitive 
selection of PR8H1N1 and H7N3. We generated H7N3PA mutant segments that have the PR8H1N1 
or H7N9 codons at amino acids 184 and 190, since these are the variable positions  in the central 
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region of PA we find determines differential polymerase activity (Figure 3.4 A). We generated 
each of these viruses as well as a H7N3 PA that has an alternative asparagine codon as a control. 
Similarly, we generated a PR8H1N1PA construct bearing the amino acids of H7N3PA at position 
184. All viruses were able to be rescued in two independent attempts and none of the PA-184-
variant viruses were attenuated relative to WT- PR8H1N1 (Figure 3.4 B).  Both H7N3 PA-P190S 
mutants were attenuated in the PR8H1N1 genetic background (Figure 3.4 B).  We then assessed 
the ability of single mutant PA-184-variant segments to function in the polymerase activity 
assay. Interestingly, the mutation PR8H1N1PA S184N reduced polymerase function by 50% and 
H7N3PA N184S had the opposite effect of generating greater than WT- PR8H1N1 activity (Figure 
3. 4 C). A silent mutation of H7N3PA N184N did not dramatically alter polymerase activity, and 
H7N3PA P190S had no activity restoration effect (Figure 3.4 C).  
We then used mutant segments bearing H7N3PA 184-variants in the head-to-head 
competition system and assessed relative incorporation compared to the wild-type PR8-H1N1 
segment. Interestingly, the N184S mutants drastically increased the H7N3 segment’s 
incorporation while P190S and Q400P in the c-terminal region had little effect on selection. 
Therefore, we conclude selection of homologous PA segments in competitive reverse genetics 
assays in human cells may be due to restriction of PA-184 residues and attenuated polymerase 
activity. 
Genome constellation present during segment selection impacts the outcome of competitive 
experiments. 
IAV genome segments have previously been hypothesized to interact with one and other 
during assembly although the process through which this occurs remains unclear. Additionally, 
myriad viral-viral and viral-host protein interactions may have profound effects on properties of 
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each newly generated reassortant virus. Examining the selection outcomes of Segment 3 in the 
H7N3 background we found that H7N3 and H7N9 segments were the predominantly selected 
strains while PR8H1N1 and other human-origin segments were selected infrequently13. Given the 
selection disparities between each background we decided to identify the genetic components of 
the inherently different selection patterns in the context of whole, replicating virus. To assess 
which segments of the genome most directly impact Segment 3’s selection we again utilized a 
head-to-head competition approach where in one segment of H7N3 was substituted for the -
PR8H1N1 segment and the other six segments were maintained. In this scheme we identified all 
segments, save HA and M as capable of altering the selection ratio of PR8H1N1PA:H7N3PA 
(Figure 3.4 C). PB2 and NA had the most drastic impact on selection, resulting in nearly 
equivalent levels of the two segments, though these viruses appears attenuated as the CT-values 
for each were lower than in a WT-PR8H1N1 background. These results suggest that the selection 
preference of PR8H1N1 PA in the PR8H1N1 context is likely driven by a required interaction 
between PA and one or more viral genes. Additionally, while possible, the co-selection of avian 
PA and PB2 seems unlikely given the replication defect observed in this assay.  
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3.5 Discussion 
Here, we uncovered a previously unappreciated genetic switch that allows certain avian-
origin polymerase genes to be incorporated into H1N1 genomes, but prevents others from 
reassortment. The selection of a single amino acid variant allows increased incorporation of 
H7N3 PA and this is due in part to increased polymerase activity. If segment selection were 
unbiased, in the presence of five options, an equal distribution of segment selection would be 
expected. The partial conservation of protein function between divergent strains likely allows 
rescue of individual reassortant viruses within a reasonable range activity. However, once past a 
threshold of packaging efficiency or minimal fitness the resulting reassortant virus will 
attenuated or non-functional. Alternatively, differences in protein-protein interactions may lead 
to the altered growth of some viruses following reassortment and unequally distributed progeny 
virus propulations21. We found that in the case of H7N3 PA, this restriction was not due to 
previously characterized genome packaging signals, nor was it due to inherent viral replication 
defects in the highly permissive MDCK cell line. Rather, we noted that in the context of a 
PR8H1N1 genetic background, a single amino acid was sufficient to increase polymerase activity 
and the likelihood of H7N3 PA segment incorporation into new virions.  
The residue we identified, PA-184, has previously been described as an epistatic 
regulator of reassortant genome polymerase activity in human cells. In the context of human 
H3N2 polymerase, insertion of H1N1 PA yields a functionally dead complex, likely explaining 
the recent history of co-assorting of PB2 and PA in human isolates11,12,22. Interestingly, this PA 
residue in the context of H3N2 depends on an additional host-restriction residue in PB2 – the 
widely studied PB2 627 residue as well as the identity of PA-383 in the same protein12. In a 
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crystal structure of the polymerase complex these amino acids reside together spatially within the 
vRNP complex to enhance association with a host factor required for replication or efficient 
transcription initiation23,24. Additionally, the PA-184 position is required for interaction with the 
host factor MCM2, important in processivity of transcription25,26. Finally, PA-184 resides near 
the second required nuclear localization signal of PA (186-247)27. Perhaps alteration of the 
biochemical properties of PA-184 in the context of some, but not other polymerase complexes 
alters the ability of either vRNPs or PA protein itself to be translocated to the nucleus. Together, 
our results indicate that the interaction of viral proteins with both host and viral components 
determines the outcome of reassortment following co-infection and polymerase activity, along 
with similar tropism and efficient genome packaging, are required for segment co-segregation in 
newly formed virus particles.  
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Figure 3.1. Reassortment potential of an H1N1 virus assessed by competitive transfection 
and individual reverse genetic rescue. A. Percentages of each reassortant virus isolated from 
culture supernatant of competitive co-transfection assay and limiting dilution assay. Genotyping 
was conducted by restriction fragment polymorphism length or Sanger Sequencing. B. Rescue 
efficiency of single gene reassortant viruses. Each reassortant virus was rescued twice 
independently and titered by TCID50 assay (Geometric Mean +/- S.E.M.).  
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Figure 3.2. Genomic context and host cell determines differential segment 3 selection and 
virus replication. A. Selection percentage determined by limiting dilution assay of head-to-head 
selection experiments in the context of either seven PR8 or seven H7N3 genome segments (n=3 
experiments). B. MDCK infection time course. 2x105 cells were plated in 24-well plates and 
infected with 250 TCID50 of the indicated virus (Geometric mean +/- S.E.M., performed three 
times in duplicate). C. Single cycle replication of PR8 7+1 PA viruses in the indicated cell type. 
2x105 cells were plated in 24-well plates and infected at MOI 5 for 24 hours in the absence of 
TPCK-trypsin to prevent re-infection. Black bars represent WT-PR8; red bars represent PR8 7+1 
H7N3 PA. (Geometric mean +/- S.E.M., performed three times in duplicate). D. Indicated cells 
were infected for 8 hours and harvested for flow cytometric analysis of nucleoprotein content.  
2x105 cells were plated in 24-well plates and infected at MOI 0.3 for 8 hours. Black bars 
represent WT-PR8; red bars represent PR8 7+1 H7N3 PA (Mean +/- S.E.M., performed three 
times in duplicate; **,  P<0.01).   
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Figure 3.3. The central region of segment 3 determines competitive selection and augments 
polymerase activity in human cells. A. Schematic of constructs used to assess the location in 
segment 3 that confers selection advantage of PR8-PA over H7N3-PA. Black regions indicate 
the region of Segment 3 that is derived from PR8-PA and red indicated H7N3-PA derived 
regions. B. Relative abundance of primarily PR8-PA or H7N3-PA segment in culture supernatant 
following competitive co-transfection and single passage on MDCK cells. Fold-change was 
determined with strain-specific TaqMan qPCR probes (N=4-6, mean +/- S.E.M.). C. Polymerase 
activity of reassortant polymerase complexes in 293T cells. All values compared to PR8-PA 
wild-type segment (N=4-6. mean +/- S.E.M.). All statistical comparisons made by one-way 
ANOVA corrected for multiple comparisons relative to PR8-PA WT in the context of the PR8-
H1N1 genome constelation (****,  P<0.001;  *,  P<0.05). 
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Figure 3.4. Identity of PA amino acid 184 and genomic context determines polymerase 
function and reassortment potential in human cells.  A Polymerase activity of single amino 
acid mutant PA polymerase complexes in 293T cells. All values compared to PR8-PA wild-type 
segment (N=4-6. mean +/- S.E.M.). All statistical comparisons made by one-way ANOVA 
corrected for multiple comparisons relative to PR8-PA WT in the context of the PR8-H1N1 
genome constelation (**,  P<0.01;  *,  P<0.05).  B. Relative abundance of primarily PR8-PA or 
H7N3-PA mutant segments in culture supernatant following competitive co-transfection and 
single passage on MDCK cells. Fold-change was determined with strain-specific TaqMan qPCR 
probes (N=4-6, mean +/- S.E.M.). C. Relative abundance of PR8-PA or H7N3-PA segments in 
culture supernatant following competitive co-transfection and single passage on MDCK cells 
when a the indicated H7N3 segment was substituted for the same PR8 segment. Fold-change was 
determined with strain-specific TaqMan qPCR probes (N=4-6, mean +/- S.E.M.; (**,  P<0.01;  
*,  P<0.05).  
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Chapter 4: 
Nucleotide resolution mapping of influenza A 
virus nucleoprotein-RNA interactions reveals 
the landscape of viral RNA features required 
for replication 
 
 
 
This chapter has been submitted in its entirety as a research manuscript that is currently in 
revision for publication at Nature Communications. 
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4.1 Abstract 
Influenza A virus nucleoprotein (NP) associates with all eight negative-sense genomic 
RNA segments during virus replication. Although the positioning of protein components within 
viral ribonucleoprotein complexes (RNPs) is well defined, the native interaction of NP with the 
viral RNA (vRNA) and the mechanisms by which a complete multi-segment genome assembles 
remain elusive. Here, we applied photoactivatable ribonucleoside enhanced crosslinking and 
immunoprecipitation (PAR-CLIP) to assess the native-state of NP-vRNA interactions in infected 
human cells. NP bound short fragments of RNA (~12 nucleotides) non-uniformly and without 
apparent sequence specificity. Moreover, NP binding was reduced at specific locations within the 
viral genome including regions previously identified as required for viral genome segment 
packaging. Synonymous, structural mutations in these low-NP binding regions impacted genome 
packaging and resulted in virus attenuation, whereas mutagenesis of NP-bound regions had no 
effect. Finally, we demonstrate that the sequence conservation of low-NP binding regions is 
required in multiple genome segments for propagation of diverse mammalian and avian IAV in 
host cells.  
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4.2 Introduction 
Influenza A virus (IAV) possesses a segmented, negative-sense RNA genome that is 
bound by the viral nucleoprotein (NP) throughout replication. The structure of the protein 
components within the viral ribonucleoprotein complex (RNP) was recently solved, but the 
structure of viral RNA and its interaction with NP have not been elucidated1,2. NP is thought to 
coat viral RNA (vRNA) uniformly in cells and virus particles; however uniform coating likely 
would preclude the possibility for RNA structure formation in RNPs. Numerous virus families 
utilize structured RNA elements for specific biological processes throughout infection, including 
genome packaging3,4. For example, viral RNA elements are required for efficient replication, 
mRNA splicing, and genome packaging of IAV5–7. Structure formation has been demonstrated 
with in vitro folded IAV vRNA and engineered genome segments but the structural constraints 
imposed by nucleoprotein on vRNA generated during infection is not known8. Elucidation of the 
physiological interaction between NP and viral genomic RNA may provide novel insights into 
how IAV is capable of coordinating its lifecycle. Thus, we set out to determine the in vivo 
landscape of NP-vRNA interactions.   
Infection and complete replication of IAV requires delivery of all eight genome segments 
into a recipient cell. All IAV segments require packaging signals derived from the termini on 
each segment9,10. Interaction between vRNAs has been demonstrated in vitro and disruption of 
packaging signals or interacting segment regions attenuated virus replication at the stage of 
genome packaging11–13. In many cases, mutation of a single segment leads to a significant 
decrease in the packaging efficiency of other segments5,14. Additionally, viral particles largely 
package only one copy of each genome segment15–17. Together, these results suggest that genome 
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segments function as a multipartite, cooperatively packaged entity, possibly potentiated by 
segment-segment interactions, rather than a stochastically generated particle18,19. In this study, we 
set out to determine how IAV NP interacts with vRNA during infection in cells.  
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4.3 Results 
Nucleotide resolution mapping of NP-vRNA interactions 
Photoactivatable ribonucleoside enhanced crosslinking and immunoprecipitation (PAR-
CLIP) coupled to next generation sequencing was used to resolve the interaction between the 
negative-sense RNA genome of IAV and NP during infection of human 293T cells20. We 
infected human cells with WT-PR8 virus for 16 h in the presence of 4-thiouridine (4-SU) to 
enhance crosslinking of NP-RNA complexes and then generated Illumina 1x50 sequencing 
libraries of the NP-bound RNA (Figure 4.1 A). The impact of 4-SU on viral replication was 
assessed in 293T cells. WT-PR8 replicated to equivalent titers 24 h post-infection (hpi) in mock- 
or 4-SU-treated (100 μM) cells (Figure 4.1 B). Additionally, NP localization after 4-SU 
treatment was assessed by confocal microscopy at 16 hpi, and no alteration was observed at this 
time point (Figure 4.1 B). These results suggest 4-SU treatment does not substantially impact 
IAV protein production or replication in human cells.  
 To determine the sensitivity and specificity of the PAR-CLIP assay, we performed 
Western blotting analysis for IAV NP and cellular ß-actin on input lysate and 
immunoprecipitated proteins (Figure 4.1 C, bottom). Compared to immunoprecipitations 
performed without antibody or a control anti-HA antibody, immunoprecipitation with a 
monoclonal antibody (MAb) against IAV NP produced a specific band. UV-exposure of infected 
cells in the presence of 4-SU enabled greater recovery of NP-RNA complexes (Figure 4.1 C, 
top). The protein purity in the immunoprecipitate was verified by silver stain or Western blotting 
with an anti-IAV polyclonal serum (Figure 4.2 A, B) or IP with a different MAb to IAV-NP 
(data not shown).  
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Influenza A nucleoprotein minimally binds 11-14 nucleotides per monomer at non-uniform 
intervals 
PAR-CLIP identified both human and virus-derived RNAs that interacted with NP. The 
procedure enriched for IAV RNA sequences relative to RNA-seq libraries (Fig 4.1 D), and the 
majority of the viral RNA sequences were derived from the negative-strand vRNA (Figure 4.3). 
The average length of the NP-bound vRNA was 12 nucleotides (range 11-14, Figure 4.1 E) and 
the distance between high confidence binding events, identified as crosslinking-induced U-to-C 
transitions in vRNA sequences, was approximately 25 nucleotides (Figure 4.1 F).  
We then compared PAR-CLIP and RNA-seq libraries to identify contiguous regions of 
vRNA that are significantly under- and overrepresented among the NP-bound RNAs. Using the 
criteria of >3-fold difference, Q<0.01, and ≥18 nucleotides long, we identified 25 regions in the 
viral genome that were low in NP binding relative to RNA-seq and 17 regions that met two of 
these three criteria that we did not investigate further (Figure 4.4 A-H, Table 4.1). Moreover, 
four high-NP binding regions that bound RNA were overrepresented relative to the control 
RNA-seq sets (Table 4.1). The low-NP binding regions together represent approximately ten 
percent of the viral genome and do not differ in base composition from the remainder of the 
genome (Figure 4.1 G). Analysis of low-NP binding regions revealed that RNA secondary 
structures might form in the absence of NP binding in some of these regions. Thus, NP binding 
might be affected by local secondary structures in the genome of IAV.  
Nucleotide identity of low-NP binding regions in Segment 5 vRNA elements is important 
for viral replication 
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To assess the significance of the over- and underrepresented RNA regions, we selected 
six regions in segment 5 that have variable NP-binding profiles (Figure 4.5 A). The lack of 
alternative reading frames and splicing and relative conservation of segment 5 compared to other 
IAV genome segments made this segment more suitable for extensive characterization. Of these, 
two regions were underrepresented (low-NP binding) in PAR-CLIP data sets (NP22-68 and NP1410-
1495). The NP1410-1495 region contains a previously hypothesized vRNA pseudoknot5. Additional 
regions of either NP intermediate binding (NP456-480, NP145-175, and NP1058-1081) or highly bound 
vRNA (NP584-608) also were also included in the following studies. Computational prediction of 
RNA structures using RNAfold in low-NP binding regions guided further mutational analysis, 
and these regions were mutagenized to either disrupt (NP22-68:A and NP1410-1495) or maintain (NP22-
68:B) secondary and tertiary structure formation (Figure 4.9). Mutant viruses bearing 2-7 
synonymous structural nucleotide changes in these regions were generated and assessed for 
ability to replicate in vitro and in vivo. 
WT and mutant viruses were subjected to a focus forming assay in MDCK cells to 
determine replication competence in vitro (Figure 4.5 B). Mutations disrupting the segment 5 
vRNA pseudoknot (NP1410-1495) formation and those predicted to destabilize a stem-loop structure 
(NP22-68:A) in the 3’ region of the vRNA segment resulted in reduction of focus area, as a measure 
of multi-cycle replication and spread (Figure 4.5 B). Conversely, mutation of intermediate- or 
highly-bound vRNA regions did not alter the focus area. Synonymous mutations in NP22-68, 
predicted to maintain the secondary structure (NP22-68:B), also did not affect focus size (Figure 4.5 
B). Multi-cycle replication assays in MDCK cells of select mutant viruses confirmed these 
results (Figure 4.5 C). Finally, mice were inoculated with 103 TCID50 of each virus, and the 
presence of infectious virus in the lung was assessed 48 h later. WT-PR8 replicated to high titers 
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at this time point whereas destabilizing mutations in low-NP binding regions resulted in 
attenuation (Figure 4.5 D). Synonymous structural mutations in intermediate or highly bound 
regions had no effect on virus infection in vivo (Figure 4.5 D). These results collectively suggest 
that structural features of the low-NP binding regions are important for IAV replication. 
To determine the cause of attenuated replication of low-NP binding mutant viruses, we 
evaluated effects on specific stages in the IAV lifecycle. All viruses displayed similar 
cytoplasmic distribution of NP 8 hpi in MDCK cells when assessed by indirect 
immunofluorescence and confocal microscopy (Figure 4.6 A). The ability of the NP proteins 
from the mutant viruses to transcribe and replicate a firefly luciferase reporter genome segment 
was tested in human cells; all viruses displayed equivalent reporter activity (Figure 4.6 B). 
Similarly, infection of MDCK cells with all viruses generated equivalent amounts of viral 
antigen (NP) 8 hpi when measured by flow cytometry (Figure 4.6 C). Therefore, the 
synonymous mutations introduced within NP segment did not alter NP expression or its activity 
by all measurable outcomes. 
We next assessed the virus particle to infectious unit ratio of WT and mutant PR8 viruses. 
The infectious titer (TCID50/ml) of NP1410-1495 and NP22-68:A mutant viruses was significantly lower 
(P<0.05) compared to all other viruses when normalized to HA-units, indicating a greater 
production of non-infectious particles (Figure 4.6 D). The ability of WT and mutant viruses to 
package all eight genome segments was assessed using a population level measure of relative 
vRNA segment abundance in purified viral particles21. RNA from WT and mutant IAVs was 
subjected to RT-qPCR and the abundance of segments was normalized to segment 7 (Figure 4.6 
E). Mutation of either the predicted pseudoknot (NP1410-1495) or stem-loop structure (NP22-68:A) 
resulted in aberrant genome constellation stoichiometry. Consistent with the viral replication 
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assays, mutation of intermediate- or highly-bound regions or mutations that maintained the 
predicted 3’ stem-loop structure (NP22-68:B) result in unaltered ratios of genome segments in all 
but one segment-specific instance (Figure 4.6 and Figure 4.7 A). These results suggest that 
RNA structure-destabilizing mutations, in regions of vRNA poorly bound by NP, impact 
replication at the stage of coordinated genome packaging. Finally, we determined the co-
expression of NP and matrix (M) proteins in singly-infected cells (Figure 4.6 F, multiplicity of 
infection (MOI) of 0.05)22. In agreement with the RT-qPCR data suggesting a packaging defect, 
a lower percentage of NP1410-1495 and NP22-68:A mutant virus infected cells co-expressed both 
proteins compared to cells infected with WT or other mutant viruses. Notably, high MOI 
infection with multiple defective particles simultaneously infecting the same cell is able to 
overcome this defect (Figure 4.7 B).  
Mutation of low-NP binding regions in additional genome segments results in attenuated 
viral replication.   
Low-NP binding regions in segments 1, 2, and 8 also were evaluated for their 
contribution to viral replication by mutagenesis designed to disrupt predicted secondary and 
tertiary RNA structures (Figure 4.8 A–C, Table 4.1). Nucleotide substitutions that alter the 
predicted RNA secondary structure but have no impact on the protein, i.e. synonymous structural 
mutation, in PB21823-1944, PB1497-561 or NS23-86 reduced the focus area of mutant viruses in MDCK 
cells (Figure 4.8 D). Similar to the attenuation of segment 5 viruses, the PB21823-1944, PB1497-561 or 
NS23-86 mutant viruses generated fewer TCID50 particles per HA-unit (Figure 4.8 E). Segment 1 
and 2 mutant viruses did not display altered reporter activity (4.10 A). Additionally, virus 
replication in mice was diminished 48 hpi compared to WT-PR8 (Figure 4.8 F). Assessment of 
vRNA abundance in virus particles revealed that segment 2 (PB1497-561) mutant viruses packaged 
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reduced levels of segment 6 vRNA (NA) (Figure 4.8 G). Manipulation of segment 8 vRNA 
sequence (NS23-86) resulted in decreased packaging of segments 3, 4, 5, and 7 relative to segment 
1 (Figure 4.8 G). Unexpectedly, the PB21823-1944 virus did not show altered segment abundance 
despite the largest in vivo replication defect (Figure 4.8 F and Figure 4.9 C) and difference in 
virus particle to infectious unit ratio. Two additional viruses with mutations in this region 
(PB21823-1944) also had reduced focus area despite no differences in segment packaging (Figure 
4.10 B, C). Together, these data suggest that vRNA sequences that are low in NP binding help to 
coordinate packaging of a full complement of eight vRNA segments and changes to the predicted 
RNA structures in these regions results in virus attenuation.  
Mutation of IAV-PR8 low-NP binding nucleotides attenuates replication of IAV-H7N3 and 
IAV-pH1N1 
 We evaluated the contribution of two low-NP binding regions (PB21823-1944 and NP1410-1495), 
identified in WT-PR8, to the replication of a North American avian IAV: 
A/shorebird/Delaware/22/2006 (IAV-H7N3) and the 2009 pandemic H1N1 strain 
A/California/04/2009 (H1N1) (IAV-pH1N1). The PB2 and NP gene-segment of IAV-PR8 and 
IAV-H7N3 are divergent and representative of mammalian and avian viruses, respectively 
(Figure 4.11 A, B). The NP gene-segment of IAV-pH1N1 is closely related to IAV-PR8 (Figure 
4.11 A), while the PB2 gene-segment is more closely related to avian viruses (Figure 4.11 B). 
Isogenic H7N3 and pH1N1 viruses, bearing synonymous mutations in the NP1410-1495 or PB21823-
1944 regions predicted to disrupt local RNA structure, were evaluated for virus replication in vitro. 
Synonymous mutations that are predicted to impact RNA secondary structure in these regions of 
IAV-H7N3 and IAV-pH1N1 attenuated viral replication, as measured by focus area (Figure 4.11 
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C, D). These results indicate that the RNA features, identified by PAR-CLIP in WT-PR8, are 
applicable to diverse avian and human strains of IAV.    
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4.3 Materials and methods 
Cells 
Madin-Darby Canine Kidney (MDCK) cells were maintained in minimal essential 
medium (MEM) with 5% fetal bovine serum (FBS, Biowest), MEM-vitamins (Gibco), L-
glutamine (Gibco), and penicillin-streptomycin (Gibco). Human embryonic kidney cells (293T) 
were maintained in Opti-MEM (Life Technologies) with 10% FBS, L-glutamine, and penicillin-
streptomycin.  
Viruses 
Eight bidirectional pHW2000 plasmids containing cDNA for A/Puerto Rico/08/1934 
(H1N1), A/California/04/2009 (H1N1), or A/shorebird/Delaware/22/2006 (H7N3) were obtained 
from St. Jude Children’s Research Hospital23. Viruses were generated by transfection of all eight 
plasmids into co-cultures of 293T and MDCK cells (1 μg per plasmid) with polyethylenimine (8 
μg total). Wild-type (herein IAV-PR8 (WT-PR8), IAV-pH1N1 (WT-pH1N1) or IAV-H7N3 
(WT-H7N3) and mutant viruses were generated in the same manner with the exception of 
substituting individual plasmids harboring mutagenized DNA for the single indicated wild-type 
plasmid. The next day, the transfection mixture was removed and replaced with Opti-MEM 
containing MEM-vitamins, L-glutamine and penicillin-streptomycin. Forty-eight hours post-
transfection, an additional 1 ml of the same media containing 1 μg ml-1 TPCK-Trypsin 
(Worthington) was added to the co-culture. Seventy-two hours after addition of TPCK-Trypsin, 
culture supernatant was harvested and clarified by centrifugation (5 min, 350 x g). Viral stocks 
were generated by infection of MDCK cells in a T75 flask. Cells were washed once with PBS, 
and 200 μL of transfection supernatant was mixed with 25 ml of infection media (M0.1B) 
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composed of MEM containing vitamins, L-glutamine, penicillin-streptomycin, 0.1% Bovine 
Serum Albumin (Gibco) and 1 μg ml-1 TPCK-Trypsin for 48 hours. Stocks were aliquoted and 
stored at -80°C until use, and all studies were conducted with passage 1 stocks following 
verification of mutant sequence identity. All viruses were generated at least twice independently. 
Sequences for primers utilized during mutagenesis of IAV plasmids are available upon request. 
 
IAV Nucleoprotein PAR-CLIP and RNA-seq Library Generation 
To identify interactions between viral RNA and IAV nucleoprotein, we adapted the 
protocol for PAR-CLIP20 coupled to Next Generation Sequencing to discern nucleotide 
resolution maps of protein-RNA interaction across the IAV genome. Confluent 293T cells were 
infected at an MOI of 1 for 16 h in the presence of 100 μM 4-thiouridine (4-SU) and then cross-
linked with ultraviolet light (310nM, 500,000 μJ total energy). PAR-CLIP was performed 
essentially as described before20 with the exception of antibodies used to immunoprecipitate NP-
RNA complexes: monoclonal antibodies HB65 (ATCC) or MAb8258 (EMD Millipore). Briefly, 
protein-RNA complexes were separated on 4-12% SDS-PAGE gels and transferred to 
nitrocellulose membranes. 32P-labeled RNA was identified by autoradiography, excised, and 
extracted following proteinase K (New England Biolabs (NEB)) digestion. To account for 
potential bias introduced during adaptor ligation and sequencing, we also generated RNA-seq 
libraries using RNA extracted from uncross-linked cell lysates of influenza infected 293T cells 
from which RNA was isolated by TRIzol (Invitrogen) extraction, fragmented by Mg2+ at 95°C 
for 12 min (NEB, Magnesium RNA Fragmentation Module). 32P-labeling of this RNA was 
performed in solution with T4 PNK (NEB), and size-selection of 10-100 nt fragments by Urea-
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Page (15%) was performed. In both cases, total RNA was precipitated with ethanol, and used to 
prepare Illumina sequencing libraries. The adaptor sequence contains NNN-degenerate 
nucleotides in addition to a sequence used for demultiplexing to facilitate collapsing of 
redundantly generated PCR products and ascertain the frequency of individual NP-RNA 
interaction events. Following isolation of adaptor ligated and radiolabeled RNA, all subsequent 
library generation steps were identical. Independent PAR-CLIP or RNA-seq libraries were 
pooled and cDNA synthesized using a primer complementary to the 3’ adaptor (SuperScript III, 
Invitrogen). Libraries were amplified by PCR for 9-15 cycles using Phusion DNA polymerase 
(Phusion HF Mastermix, Thermo) and primers annealing to the 5’ and 3’ termini of the DNA 
that enable flow-cell binding. Size selection of libraries was conducted by extraction of 
amplicons from 6% urea gel electrophoresis, and then libraries were precipitated. Molarity of 
libraries was determined by qPCR (NEBNext, New England Biosciences) and size by 
Bioanalyzer (Agilent). Illumina sequencing on the HiSeq 2500 instrument (1x50bp reads) was 
performed by the Genome Technology Access Center at Washington University in St. Louis.  
 
Next Generation Sequencing  
All NGS data was analyzed on the Washington University in Saint Louis School of 
Medicine’s McDonnell Genome Institute (MGI) cluster using publically available analysis 
programs (FastX toolkit, Bowtie, and SAMtools) and in-house scripts20. PAR-CLIP and RNA-
seq data were generated from four independent experiments. For PAR-CLIP and RNA-seq 
libraries we used an analysis pipeline that collapsed unique barcoded reads, removed adaptors, 
and aligned them to the viral genome. Strandedness was determined post-alignment and all 
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subsequent analysis was performed on negative-sense viral genomic RNA (vRNA). For reads 
that mapped to the viral RNAs, we normalized the number of reads per nucleotide to the total 
number of reads per genome segment to yield a normalized coverage ratio for both PAR-CLIP 
and RNA-seq libraries. We then compared the normalized coverage for each preparation at 
nucleotide resolution using an unpaired t-test with False Discovery Rate (FDR) correction 
(Benjamini-Hochberg)24. vRNA nucleotides with a FDR minima Q < 0.01 and fold-change >3 
were identified and these regions were extended to the final nucleotide of each region where Q ≤ 
0.1. These areas represent low-NP or high-NP binding regions of interest (ROI). ROI ≥ 18nt 
were subjected to RNA structure analysis with mFold, RNAfold, and vsFold5 to determine 
computationally the theoretical minimal free energy (ΔG) of each region as well as the potential 
secondary or tertiary RNA structure formation25,26. Nucleotide composition of ROIs was 
determined by calculating the percent of A, G, C, or U in each region and comparing them to the 
percent of each nucleotide in the IAV genome. The approximate periodicity of NP-vRNA 
interactions was determined by assessing the nucleotide distance between U-to-C transition sites 
in vRNA. UV-crosslinking of 4-SU to IAV NP introduces a U-to-C transition upon reverse 
transcription of vRNA due to the residual covalent protein adduct left on the thiouridine base 
after proteinase K digestion and RNA recovery. PAR-CLIP data sets were compared to RNA-seq 
data sets at each nucleotide position on a per-segment basis and positions using unpaired t-test 
with FDR correction as above with a threshold of Q = 0.05. Sites of statistically enriched 
transition in PAR-CLIP data sets were tabulated and the sequence distance between these 
positions was calculated. Transition events with a step-size of 1, i.e. sequential nucleotides both 
with high transition rate, were excluded from analysis because they likely represent single NP-
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RNA interactions of adjacent 4-SU nucleotides in vRNA. Transition rate for four PAR-CLIP 
libraries were averaged prior to distance calculation.  
Selection, Design, and Generation of IAV Containing Altered RNA structures 
Mutant selection was performed after analysis of open reading frames to assess potential 
nucleotide degeneracy while retaining coding sequence. Subsequently, we selected five 
underrepresented ROIs in four segments (1, 2, 5, and 8) for functional assessment of 
manipulating RNA structure on viral replication. We also identified four regions in segment 5, 
amenable to extensive silent mutagenesis that were either highly bound or represented at the 
same frequency in PAR-CLIP and RNA-seq data sets. We introduced between 2 and 7 
synonymous mutations simultaneously in silico to the identified regions and reassessed structural 
stability or pseudoknot formation using the same structure prediction programs. We selected 
variant codon combinations that would disrupt or maintain the predicted vRNA structure but not 
change the encoded amino acid, alter codon usage, or disrupt alternative reading frames or 
splicing events. Once predicted destabilizing mutations were identified, mutant viruses were 
generated. Mutations were introduced into pHW2000 bidirectional plasmids by inverse PCR 
with primers including selected mutations and unique ligation sites. PCR products were gel 
extracted and digested with either BsmbI (New England Biolabs, (NEB)) or AarI (Thermo Fisher 
Scientific) restriction enzymes and DpnI (NEB) to remove residual parent plasmid. Digested 
PCR products were PCR purified and ligated using Instant Sticky End Ligase (NEB). Ligation 
products were transformed into E. coli, plated on selective LB Agar. Colonies were selected and 
grown overnight in LB broth and selective antibiotics. All plasmids were grown in 200 ml LB 
Broth prior to preparation by Qiagen HiSpeed Endotoxin-Free MaxiPrep and verified by Sanger 
Sequencing (Genewiz).  
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Influenza A Virus Focus Forming Assay 
Six-well plates of MDCK cells were plated and inoculated with 1 ml of 10-fold serially 
diluted virus stock for 1 h in M0.1B. After 1h, the inoculum was removed, and replaced with an 
overlay of 1% Low Melting Point Agarose in MEM supplemented with 1 μg ml-1 TPCK-Trypsin. 
Seventy-two hours post infection cells were fixed in 5% formaldehyde, permeabilized with 0.1% 
saponin in HBSS, and stained for NP protein with biotinylated anti-NP (mAB8258b, Millipore). 
Foci were visualized by addition of HRP-conjugated streptavidin and TruBlue streptavidin 
substrate and imaged on a Biospot reader (Cellular Technology Limited). Individual foci were 
counted and area was calculated using the Analyze Particles extension within Fiji27. The area of 
the foci formed by mutant viruses was normalized to the average of WT-PR8 foci per 
experiment. A minimum of 60 foci was analyzed per virus.  
Confocal Microscopy 
We infected 293T cells in the presence or absence (mock) of 4-SU with WT-PR8 (MOI 
of 1) for 16 h. Briefly, 293T cells were seeded on glass coverslips coated with poly-D lysine 
overnight. Cells were infected with WT-PR8 for 16 h then fixed with 4% methanol-free PFA in 
PBS (pH 7.4), washed with PBS, permeabilized with saponin, then NP staining was performed 
using anti-NP MAb HB65 and goat-anti-mouse Alexa-488 (Invitrogen). Nuclei were 
counterstained with DAPI. Coverslips were mounted to slides with ProLong® Diamond Antifade 
Mountant (Molecular Probes). To determine if viral protein production was impacted by 
synonymous mutations, we utilized confocal microscopy to visualize the distribution of NP 
during infection as a marker of viral protein production and a proxy for trafficking of vRNPs. 
MDCK cells were infected with WT-PR8 and indicated mutant viruses (MOI of 0.2) for 8 h then 
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fixed and permeabilized as before. NP staining was performed as above using anti IAV-NP MAb 
HB65 and Goat-anti-Mouse Alexa-488 (Invitrogen). Slides were imaged with Zeiss LSM 880 
Confocal Laser Scanning Microscopy with Airyscan and analyzed with Zeiss Zen Black 
Software performed within the Molecular Microbiology Imaging Facility at Washington 
University in Saint Louis.  
Influenza A virus Reporter Assay 
To assess the impact of silent mutations on polymerase complex activity, pHW2000 
plasmids encoding WT or mutant PB2, PB1, PA, and NP were utilized in a dual-luciferase 
reporter assay as previously described23. A vRNA-like firefly luciferase reporter plasmid and a 
Renilla luciferase expression plasmid also were included. Briefly, 293T cells were seeded into 
24-well plates and transfected with equal amounts of all six plasmids (500ng DNA total) in Opti-
MEM containing TransIT-LT1 (Mirus). Cells were maintained at 37°C for the duration of the 
experiment. Forty-eight hours later, cells were lysed for analysis of luciferase activities 
(Promega). Each combination of polymerase proteins (set of plasmids) was examined in 
duplicate. The relative light units (RLU) of firefly luciferase activity were normalized to the 
RLU for Renilla luciferase activity within the same sample to account for differences in 
transfection efficiency between wells and experiments. The activity of each plasmid set 
containing a mutant segment was normalized to the activity of WT-PR8.  
Flow Cytometry 
To determine the amount of NP generated at a fixed time during infection, we infected 2 
x 105 MDCK cells (MOI of 0.2). Eight hours post-infection, cells were harvested and fixed. 
Intracellular staining of IAV antigen was performed as above using an anti-IAV NP primary 
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antibody (HB65) and an Alexa-488-conjugate goat-anti-mouse secondary antibody (Invitrogen). 
The mean fluorescence intensity (MFI) of NP+ cells was plotted and calculated from two 
experiments performed in duplicate. Co-expression of NP and M in MDCK cells was determined 
16 hpi with an MOI of 5 and 0.05. Infected cells were fixed and stained as above with the 
additional staining step of utilizing mouse-anti-M primary antibody (M2-1C6) and goat-anti-
mouse Alexa-647 secondary. A second intracellular staining step utilizing biotinylated mouse-
anti-NP (mAb8258b) and Alexa-488 conjugated streptavidin was then performed. The frequency 
of co-expression was calculated by determining the number of cells expressing NP or M as well 
as those expressing both. The percentage of infected cells co-expressing NP and M was 
calculated by dividing co-expressing cells by all cells expressing one or more viral protein as 
previously described22. Analysis of viral proteins was determined using a flow cytometer and 
FlowJo software (Tree Star). 
Multi-step Replication of Influenza A virus 
MDCK cells (2 x 105) were seeded in 24-well plates and inoculated the next day with 200 
TCID50 of IAV. Cells were washed once with PBS before addition of inoculum in M0.1B and 
incubated for 1 h at 37°C. Subsequently, the cells were washed twice with PBS and 1 ml of 
M0.1B supplemented with 1 μg ml-1 TPCK-Trypsin was added to each well. Culture 
supernatants were collected at 24 and 48 hpi and the amount of infectious virus was quantified 
by titration on MDCK cells.  
Titration of Influenza A virus (TCID50) 
Confluent monolayers of MDCK cells were grown overnight in 96-well tissue culture 
plates. The next day the cells were washed with PBS and inoculated with ten-fold serial dilutions 
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of culture supernatant or lung homogenate for one hour in M0.1B at 37°C. After 1 h the 
inoculum was removed and replaced with M0.1B supplemented with 1μg ml-1 TPCK-Trypsin 
and incubated for 72 hours. Presence of virus was determined by hemagglutination assay using 
0.5% turkey red blood cells. TCID50 was determined by the Reed-Muench method28.  
Infection of mice with influenza viruses 
Male C57BL/6J mice (5 to 6 weeks of age) were bred in-house in a barrier facility at 
Washington University School of Medicine, St. Louis, MO or purchased from Jackson 
Laboratories. Mice received food and water ad libitum and all experiments were conducted in 
accordance with rules of the Institutional Animal Care and Use Committee. Mice were 
anesthetized with isoflurane in an airflow chamber and then inoculated intranasally with 30 μL 
of sterile PBS containing 1,000 TCID50 of WT-PR8 or the indicated mutant virus. Forty-eight 
hours post-infection, lungs were harvested and homogenized in 1ml M0.1B, cleared by 
centrifugation at 1,200 x g for 5 minutes, then stored in aliquots at -80°C. Viral titers from lung 
homogenates were determined by TCID50 assay.  
Segment Abundance RT-qPCR 
MDCK cell derived stocks of WT-PR8 or mutant viruses were clarified by centrifugation 
at 1,200 x g for 5 min, passed through a 0.22 µM filter, and pelleted on 30% sucrose cushion by 
ultracentrifugation (Beckman SW32ti swinging bucket rotor, 27K RPM, 4°C for 90min). 
Pelleted virus particles were directly resuspended in 350 μL TRK lysis buffer, and RNA purified 
immediately and eluted in 30 μL DEPC H2O (Total RNA Kit I, Omega). cDNA was synthesized 
from 5µL of RNA with SSIII Reverse transcriptase (Invitrogen) and a vRNA specific primer21. 
Total cDNA was diluted 1:10,000 and used to quantify each of the 8 genome segments by SYBR 
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Green qPCR (PowerUpTM SYBR® Green Master Mix) with primer pairs previously published. 
Relative abundance of each genome segment was calculated as before, except with normalization 
to Segment 1 or 7 depending on the virus assessed.  
Statistical Analysis 
All statistical analysis was performed using GraphPad Prism 7.0. For comparison of 
PAR-CLIP and RNA-seq data sets, we used multiple unpaired t-tests with the Benjamini-
Hochberg correction to identify areas in which these sequencing preparations were statistically 
different from each other (Q < 0.1 and Q < 0.01). Transition-distance was determined using FDR 
(Q < 0.05). For analysis of the focus forming assay, luciferase assay, and lung viral titers we 
used one-way ANOVA with multiple comparison corrections (Kruskal-Wallis test). TCID50 per 
HA-unit was analyzed using an unpaired t-test.  
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4.5 Discussion 
We have identified the interaction landscape of IAV NP with viral RNA in the context of 
infected cells. Our findings indicate that binding of NP to viral RNA is restricted to an average of 
12 nucleotides and the distance between two crosslinking sites is 25 nucleotides. These estimates 
agree with molecular models of NP-RNA interactions and the NP-binding footprint of a related 
orthomyxovirus1,19,29,30. Within this model, NP is excluded from consistent interaction with 
specific regions of vRNA and allows trans-interactions with either other genome segment vRNA 
or host and virus factors. The interaction between NP and the viral RNA was non-uniform and 
characterized by regions that were consistently low- or high in NP binding. More than half of the 
low-NP regions have potential to form secondary and tertiary RNA structures, based on 
computational analysis, and mutations that are predicted to alter the stability of these RNA 
structures resulted in attenuated virus infection (summarized in Table 4.2). The presence of 
RNA structures in RNP complexes may explain the pleomorphic nature of RNPs31. Several, 
mostly shorter low-NP binding regions were not predicted to form stable structures. These 
regions may represent a portion of a larger RNA structure or have a yet unknown function during 
IAV replication to the fact that they are consisted of shorter sequences, had no detectable impact. 
These regions may represent a portion of a larger but less stable structure or have a different yet 
unknown function during IAV replication. We examined NP-vRNA interactions at a late time 
point when a majority of viral RNA is distributed throughout the cytoplasm and thought to be 
within vRNP complexes. In support of this, the great majority of PAR-CLIP reads were obtained 
from negative sense vRNAs. 
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We found many low-NP binding RNA regions that overlap with previously predicted 
packaging and bundling signals near segment termini (NP22-68, NP1410-1495, and NS23-88)5,32. 
However, additional low-NP binding regions were identified throughout the segment body and 
outside of traditional packaging singals10,21,33. Our findings agree with studies assessing structure-
guided mutagenesis of hypothetical vRNA structures (segment 7) or biochemical analyses of 
vRNA (segment 8) that largely overlap with low-NP binding regions assessed here7,34. 
Additionally, we identified specific nucleotides required for co-packaging of segment 2 (PB1) 
and segment 6 (NA), in a region recently implicated in directing reassortment outcomes and co-
segregation of these segments in vitro35,36. Therefore, NP PAR-CLIP allowed us to directly 
identify potentially functional RNA regions in IAV genomes required for coordinated genome 
packaging. 
As predicted RNA structures in the low-NP binding regions are important for genome 
packaging, it suggests a requirement for inter-segment RNA interactions. Specific RNA 
interactions between genome segments have been demonstrated in vitro and ablation of these 
interactions lead to aberrant genome packaging; an outcome reversed by introduction of 
compensatory mutations in the interacting segment11. Many of the mutations that alter genome 
assembly also lead to an increase in number of defective viral particles32. The formation and 
nature of vRNA structures is likely contingent on the sequence composition and physical 
position of the nucleotides within a RNP complex. 
IAVs can reassort and generate novel and potential pandemic strains. We tested if the 
regions identified in IAV-PR8 were required for replication of a divergent H7N3 virus. 
Synonymous structural changes in the same vRNA regions of two separate segments in both 
IAV-H7N3 and IAV-pH1N1 were attenuating and suggest conservations of these structural 
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elements. Future examination of NP-binding of viral RNA in diverse strains of IAV is likely to 
identify overlapping and distinct high and low-NP binding regions. These RNA features may be 
required for all viruses as coordinating packaging elements, but additional regions act as strain or 
lineage specific packaging enhancers. Further, these strain or lineage specific RNA features, 
required for genome packaging, may act as potential determinants of reassortment outcomes. 
Prior experimental systems demonstrated that co-segregation of genome segments occurs during 
natural reassortment as well as lab-adaptation of virus strains to create new vaccines23,36. Finally, 
attenuation of genome packaging through silent, structural mutations has the potential to 
accelerate live attenuated vaccine production using native genome constellations to allow 
vaccination with all protein epitopes of a novel pandemic virus, without the need for master 
donor strains. 
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Figure 4.1. Development of PAR-CLIP for IAV NP 
a, Schematic for IAV NP PAR-CLIP assay. b, Effects of 4-SU (100 μM) on attenuate IAV 
replication was assessed by TCID50 assay (bottom) or confocal microscopy (top). 
Immunofluorescence staining for NP (green) was assessed in the presence or absence of 4-SU 
and counterstained with DAPI to identify cellular nuclei (blue). c, PAR-CLIP was conducted on 
293T cells infected with WT-PR8 in the absence (lanes 1 and 2) or presence of a monoclonal 
antibody against to IAV NP (lanes 3-6) or viral hemagglutinin protein (HA) (lanes 7-8). The 
effect of UV cross-linking on binding of RNA to the viral NP is shown in lanes 3-4 (no UV) and 
lanes 5-6 (with UV). Radioactivity (32P) is visualized by autoradiograph and the presence of 
absence of NP and cellular ß-actin was done by western blot. The input sample and eluate are 
loaded in the uneven and even lanes respectively. The results are representative of four 
independent experiments. d, Proportion of PAR-CLIP or RNA-seq derived reads mapping to 
human or IAV genomes (**, P < 0.01, n = 4). e, Length of negative-sense viral RNA (vRNA) 
aligning reads was determined using FastX Toolkit and the number of reads of a certain length is 
plotted as a proportion of total vRNA mapping reads. Mean (black line) +/- S.E.M. (blue 
shading) of 4 experiments. f, Nucleotide distance between crosslinking-induced A-to-G 
transitions in vRNA mapped PAR-CLIP data (mean + S.E.M. of 4 experiments). g, Nucleotide 
composition of low-NP binding  regions and IAV genome (displayed as average base 
composition of all eight gene-segments) . No significant differences were detected between 
groups.  
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Figure 4.2. NP immunoprecipitation protocol results in pure NP elution. a, Silver stain of 
immunoprecipitation (IP) eluate for IAV infected cells with either anti-HA or anti-NP antibodies. 
The upper band represents NP and lower band represents IgG heavy chain. Gel image is 
representative of two independently performed experiments b, IP of NP from purified virus 
particles removes all other viral proteins. Western blot using polyclonal goat sera against H1N1 
virus to detect all viral proteins in input and NP-immunoprecipitated eluate. Lane 1 is a marker, 
lanes 2 and 3 are control immunoprecipitation beads in which no virus lysate was added. Lanes 4 
and 5 are input or IP eluate from virus lysate immunoprecipitated with anti-NP antibody HB65. 
The membrane was probed with goat-anti-IAV USSR (H1N1) (US Biological, I7650-78B) and 
IRDye 800CW donkey-anti-goat (Licor). Gel image is representative of two independently 
performed experiments. 
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Figure 4.3. NP binds negative-strand IAV genome and immunoprecipitated RNAs are 
representative of total cellular IAV RNA levels. Percentage of mapped reads derived from 
negative-sense viral RNA (vRNA) for four PAR-CLIP experiments (mean + S.E.M., n = 4) and 
PAR-CLIP and RNA-seq sequence abundance per gene segment (vRNA only) of IAV. 
Calculated as the total number of base calls per segment and normalized to segment 1 (mean + 
S.E.M., n = 4 each). 
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Figure 4.4. Nucleoprotein binding is non-uniform in all eight IAV genome segments. a-h, 
Normalized coverage for complete genome segments for PAR-CLIP (red) and RNA-seq (black). 
Lines represent mean +/- S.E.M from four experiments each.  
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Figure 4.5. Manipulation of vRNA in low-NP binding regions that disrupts predicted RNA 
structure attenuates virus replication  
a, Normalized coverage +/- S.E.M was determined for each nucleotide in the PAR-CLIP (red 
symbols) and RNA-seq (black symbols) libraries (n = 4 each). Six regions of interest (ROI) in 
segment 5 (NP) are highlighted including two low-NP binding regions (NP1410-1495 and NP22-68), 
one high-NP binding region (NP584-608) and three intermediate NP-binding regions (NP145-175, 
NP456-490, and NP1058-1081). Each ROI is indicated with a colored bar. b, Focus area of WT-PR8  
and NP mutant IAV. MDCK cells were infected with serial dilutions of the indicated viruses and 
overlayed with infection media (M0.1B) containing 1% agarose and TPCK-trypsin. Seventy-two 
hours later cells were fixed, permeabilized, and stained for viral antigen (NP). Focus diameter 
was determined and normalized to WT-PR8 per experiment. Results are the average + S.E.M. of 
3-5 experiments per virus (> 60 foci each). c, MDCK cells were infected with MOI=0.001 of the 
indicated viruses and culture supernatant was collected at indicated time points then titered on 
MDCK cells. Results are the average +/- S.E.M. TCID50/ml of two experiments performed in 
duplicate. d, C57BL/6J mice were inoculated with 103 TCID50 of the indicated viruses in 30µL. 
Lungs were collected, homogenized, and titered on MDCK cells. Each dot is a single mouse and 
the line is the geometric mean. Dotted line in c and d represents the limit of detection. (***, P < 
0.005; **, P < 0.01; *, P < 0.05; n.s., not significant) 
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Figure 4.6. Attenuating mutations in segment 5 impact coordinated genome packaging 
a, Confocal microscopy images depicting the localization of nucleoprotein (NP) eight hours post 
infection (hpi). MDCK cells were infected with the indicated virus (white text), and NP was 
identified using the MAb HB65 and Alexa-488 conjugated goat-anti-mouse secondary antibody 
by immunofluorescence. Cell nuclei are counterstained with DAPI. Panels depict the merged 
image of DAPI and NP staining. Fields are representative of two independent experiments. b, 
Dual-luciferase reporter assay to assess viral transcription and genome replication, each 
combination of plasmids was assessed 3-5 times with corresponding the WT-PR8 combination. 
c, Mean fluorescence intensity (MFI) of NP in virally infected MDCK cells (MOI = 0.05, 
experiments were performed twice in duplicate) as revealed by flow cytometry. d, Viral titer 
(TCID50/ml) of 4 HA-units of WT-PR8 and mutant viruses. Results are the average of three viral 
titrations and two HA assays per infectious virus titration (TCID50 assay and HA titration 
experiments, average MFI + S.E.M). e, Proportion of infected cells co-expressing of matrix (M) 
and NP proteins in singly infected MDCK cells (MOI = 0.05) 16 hpi as revealed by flow 
cytometry. The average percentage of co-expression was calculated from two experiments 
performed in duplicate. f, Relative abundance of genome segments in purified WT or mutant 
viruses. All segments were compared to segment 7 (M) vRNA and normalized to the average of 
WT-PR8 values using the 2-ddCt method55. Bars represent the mean of 3-6 independent virus 
preparations + S.E.M. (*, P < 0.05; n.s., not significant) 
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Figure 4.7. Additional mutations in NP-bound regions have minimal effect on coordinated 
genome packaging and decreases in viral protein co-expression may be overcome by high 
multiplicity of infection. a, Packaging qPCR of additional mutant viruses, as in Figure 3f (*, P 
< 0.05). The relative abundance of each genome segment in concentrated virus particles was 
assessed and normalized to Segment 7 and WT-PR8 virus by the 2-ddCT method as stated in the 
materials and methods. b, co-expression of M and NP proteins in MDCK cells infected at high 
MOI (5) for 16 hours. High MOI infection of MDCK cells overcomes co-expression defects 
observed at low MOI (Figure 3e). Proportion of infected cells co-expressing of NP and M was 
determined by calculating the number of NP+M+ double positive cells and dividing by the total 
number of cells expressing NP or M when assessed by flow cytometry. Results are derived from 
two independent experiments performed in duplicate. 
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Figure 4.8. Synonymous structural mutations in low-NP binding regions in Segments 1, 2, 
and 8 attenuated virus replication and genome packaging. 
a-c, Segment 1 (a, blue line), 2 (b, grey line), and 8 (c, green line) low-NP binding regions  
defined by PAR-CLIP analysis. Normalized coverage +/- S.E.M was determined for each 
nucleotide in the PAR-CLIP (blue, grey or green symbols) and RNA-seq (black symbols) 
libraries (n=4 each). d, Relative focus area of WT-PR8 and segment 1, 2, and 8 mutant viruses. 
Bars are the average + S.E.M. of 3 experiments per virus (> 60 foci each). e, Viral titer 
(TCID50/ml) of 4 HA-units of WT-PR8 and mutant virus. Results are the average of three viral 
titrations and two HA assays per infectious virus titration (TCID50 assay and HA titration 
experiments, average MFI + S.E.M). f, C57BL/6J mice were inoculated with 103 TCID50 in 
30µL. Lungs were collected 48 hpi, homogenized, and titered. Each dot is a single mouse and the 
line is the geometric mean. Dotted line in f represents the limit of detection. e, Relative 
abundance of genome segments in purified WT or mutant viruses. All segments were compared 
to segment 1 (PB2) vRNA and normalized to the average of WT-PR8 values using the 2-ddCt 
method55. Bars represent the mean of 3-6 independent virus preparations + S.E.M. (***, P < 
0.005; **, P < 0.01; *, P < 0.05; n.s., not significant). 
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Figure 4.9. Predicted RNA structure of WT-PR8 and the indicated mutant viruses. In all 
cases the nucleotides substituted are highlighted and WT-PR8 structures are to the left of the 
arrow. a, alteration of a previously identified pseudoknot within the NP1410-1495 vRNA region. 
Alteration of predicted secondary structures in the indicated vRNA regions for NP22-68 region 
(b), PB1497-561 (c), NS23-88 (d). and PB21823-1944 (e).  
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Figure 4. 10. Multiple mutations in Segment 1 unbound region attenuate focus formation 
but do not lead to apparent segment-specific packaging defects. a, Dual-luciferase reporter 
assay to assess viral transcription and genome replication, no significant differences observed 
(average + S.E.M. of three experiments performed in duplicate). b, Relative focus area of WT-
PR8 and segment 1 mutant viruses (n=3 experiments per virus, area for > 40 total foci per virus 
calculated). c, Relative abundance of genome segments in purified WT or mutant viruses. all 
segments were compared to segment 1 (PB2) vRNA and normalized to the average of WT-PR8 
values using the 2-ddCt method55. Bars represent the mean of 3-6 independent virus preparations + 
S.E.M. (***, P < 0.005; **, P < 0.01; *, P < 0.05; n.s., not significant). 
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Figure 4.11. vRNA regions required for PR8 replication are required for replication of 
contemporary avian and human IAV. 
a, Phylogenetic analysis of segment 5. WT-PR8, WT-H7N3, or WT-pH1N1 IAV are indicated 
by corresponding, labeled arrows. Phylogenies were created from randomly sampled full-length 
segment 5 sequences downloaded from NCBI IVR. Alignment performed in MEGA (version 7) 
using MUSCLE. Phylogenetic trees created using the Maximum Parsimony method included in 
MEGA. Phylogenies were visualized in FigTree and manually annotated. Green shading 
represents segment sequences derived from avian viruses; red represents human viruses; and blue 
represents swine viruses. b, Phylogenetic analysis of segment 2 performed as in (a). c, Relative 
focus area of WT-H7N3 and mutant viruses + S.E.M. d, Relative focus area of WT-pH1N1 and 
mutant viruses + S.E.M. ****, P < 0.001; 3 experiments, > 60 foci per virus with three 
independent experiments performed per virus.  
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Segment 1 
Low (nt) FDR min Fold-change Length High (nt) FDR min 
Fold-
change Length  
307-333* 0.01 >3 >18 117-150 0.01 <3 >18 
408-431 0.05 >3 >18 2141-2159 0.05 >3 >18 
1089-1121 0.05 >3 >18 
    
1823-1944* 0.01 >3 >18 
    
2321-2341 0.05 >3 >18 
    
 
Segment 2 
Low (nt) FDR min Fold-change Length High (nt) FDR min 
Fold-
change Length  
297-419* 0.01 >3 >18 39-56* 0.01 >3 >18 
465-482 0.01 <3 >18 2178-2195 0.01 <3 >18 
497-561* 0.01 >3 >18 
    
930-955* 0.01 >3 >18 
    
1294-1314 0.05 >3 >18 
    
1423-1440* 0.01 >3 >18 
    
1521-1576 0.05 >3 >18 
    
1746-1773* 0.01 >3 >18 
    
1790-1817* 0.01 >3 >18 
    
 
Segment 3 
 
Low (nt) 
FDR min Fold-change Length 
619-640 0.05 >3 >18 
792-817 0.05 >3 >18 
1098-1113 0.01 >3 16 
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Segment 4 
Low (nt) FDR min 
Fold-
change Length Low (nt) FDR min 
Fold-
change Length  
208-240* 0.01 >3 >18 98-151* 0.01 >3 >18 
252-282 0.05 >3 >18 980-1009 0.05 >3 >18 
376-430* 0.01 >3 >18 1446-1463 0.01 <3 >18 
441-464 0.05 >3 >18 
    491-528 0.05 >3 >18 
    602-628 0.05 >3 >18 
    1256-1340* 0.01 >3 >18 
    1585-1661* 0.01 >3 >18 
    1719-1770* 0.01 >3 >18 
     
Segment 5 
Low (nt) FDR min Fold-change Length High (nt) FDR min 
Fold-
change Length 
22-68* 0.01 >3 >18 634-661 0.01 <2 >18 
261-329 0.01 >3 >18 766-787* 0.01 >3 >18 
337-378 0.01 >3 >18 
    
1410-1495* 0.01 >3 >18 
    
1514-1560* 0.01 >3 >18 
    
 
Segment 6 
Low (nt) FDR min Fold Length High (nt) FDR min Fold Length 
249-269* 0.01 >3 >18 1181-1199 0.05 >3 >18 
849-866 0.05 >3 >18 
    
1038-1057* 0.01 >3 >18 
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1080-1197 0.05 >3 >18 
    
 
Segment 7 
Low (nt) FDR min Fold Length  High (nt) FDR min Fold Length 
1-16 0.01 >5 16 601-632* 0.01 >3 >18 
142-201* 0.01 >3 >18 
    
640-660* 0.01 >3 >18 
    
839-866 0.05 >3 >18 
    
 
Segment 8 
Low (nt) FDR min Fold Length  High (nt) FDR min Fold Length 
23-86* 0.01 >3 >18 413-430 0.05 >3 >18 
113-139 0.05 >3 >18     
867-885* 0.01 >3 >18     
 
Table 4.1. Low- and High-NP bound regions of vRNA. 
Regions of vRNA greater than or equal to 18 nucleotides long and meeting criteria described in 
the methods. NP-low indicates the region was significantly lower in PAR-CLIP than RNA-seq 
and NP-high indicates the region was significantly higher in PAR-CLIP than RNA-seq. FDR 
Minima is the minimum False Discovery Rate for each region. Fold-change is absolute fold-
difference between PAR-CLIP and RNA-seq data. The regions that meet all three criteria are 
denoted with asterisks, while those meeting two are not.  
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Virus NP-bound 
WT  
–ΔG 
(MFE) 
Effect of 
Mutations 
Effects on Virus 
Focus 
Size 
Lung 
Titer 
HA:TCID50 
Ratio 
Segment 
Packaging 
H7N3 
and 
pH1N1 
Shared 
NP 
22-68:A -- -8.7 ê–ΔG êê ê êê êê N.D. 
NP 
22-68:B -- -8.7 No effect = = = = N.D. 
NP 
145-175 = -8.0 ê–ΔG = = = = N.D. 
NP 
456-490 
= -3.2  No effect = = = = N.D. 
NP 
584-608 ++ -0.0 No effect = = = = N.D. 
NP 
1058-1081 = -0.0 No effect = = = = N.D. 
NP 
1410-1495 -- -19.8 
Modified 
Pseudoknot êê êê êê êê ++ 
         
PB2  
1823-1944 
-- -33.0 Modified Pseudoknot ê êê êê êê ++ 
PB1  
497-561 -- -12.9 ê –ΔG ê ê êê êê N.D. 
NS 
23-88 -- -10.0 
Modified 
Pseudoknot êê ê êê êê N.D. 
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Table 4.2. Disruption of potential RNA structural elements contributes to virus 
attenuation.  
For NP-binding the following categories were considered: --, significantly lower that WT-PR8; 
=, equal to WT-PR8; ++, greater than WT-PR8. The regional stability was determined in WT-
PR8 and mutant virus using Vienna RNAfold. MFE: minimum free energy. All calculations were 
performed using the default settings without imposing structural constraints. Pseudoknot 
formation potential was performed using vsFold5 and default settings. Results for focus area, 
lung titer, TCID50/ml:HA ratio, relative segment packaging and conservation in 
A/shorebird/Delaware/22/2006 (H7N3) are summarized from previous figures (=, equivalent to 
WT-PR8; ê, P < 0.05; êê, P < 0.01).  
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Chapter 5: 
Conclusions and Future Directions 
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5.1  Production and packaging of eight segments complicates IAV evolution 
Influenza A viruses (IAV) possess eight genome segments that must be co-packaged into 
nascent virions to enable fully productive subsequent infection1. Throughout prior chapters, I 
have discussed the individual components of IAV genome packaging, reassortment, and how 
congruence between viral factors, RNA and protein, are required for generation of genetically 
diverse infectious virus, propagation, and pathogenesis. Herein, I will discuss the layers of 
genetic compatibility we found to be a pretext for the potential of reassortment, as well as 
unresolved and newly generated questions which future studies may be directed towards. 
5.2  Environmental and cellular requirements for reassortment  
The potential for pandemic formation of antigenically novel viruses necessitates 
simultaneous replication of parent viruses in a single host cell2. For contemporaneous cellular 
infection to occur a singular virus must have the ability to infect a host via either the respiratory 
(in mammals) or oral-fecal (in birds) route, establish replication, and spread within the target 
tissue. Additionally, once a singular virus has infected and established replication, the secondary 
virus must co-infect the host and disseminate to a shared site of replication. Recent studies 
demonstrate that tissue localized co-infection must be relatively contemporaneous, otherwise the 
host innate immune system likely suppresses the chances for super-infection2,3. The speed of co-
infection on an organismal level has not been exhaustively studied, but the cellular time scale has 
been assessed in vitro3. In Chapters 2 and 4, I explored a method to bypass the required cellular 
co-infection by utilizing an in vitro co-transfection protocol4. By so doing, we minimized 
temporal and spatial issues related to co-infection. The results from those reassortment screens 
demonstrated that genetic as well as host factors are important determinants of what potential 
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new viruses may emerge. Subsequent sections of this chapter will focus on these findings and 
expound upon implications for viral evolution. 
5.3  Reassortment may augment the fitness of viral quasispecies to overcome 
replication and transmission bottlenecks.  
Segmentation, while complicating genome packaging, increases the potential for 
exploration of sequence space within and between multiple hosts following reassortment5,6. 
Influenza viruses have an error prone polymerase (PB1), generating 5x10-5 mutations per 
genome segment copied, therefore each new virus genome may contain 2 or 3 de novo 
mutations7,8. As such, the potential for acquisition of both beneficial and deleterious mutations at 
the RNA or protein level are possible. Recent studies on viral quasispecies demonstrate that 
variations in the mutation rate itself can be deleterious to viral fitness7,9. However, if a mutation 
is acquired in one segment, this allows transfer of evolved genetic information to a new genome 
constellation. In the case of beneficial mutations, such as those that overcome species-specific 
restriction factors, acquisition of a segment bearing this signature may enable host range 
diversification5. Conversely, if a deleterious mutation is acquired, it may be rapidly purged from 
the quasispecies with little consequence to the population at large. Additionally, the rapid within-
host divergence likely alters the between host transmission potential, as this is both a physical 
and genetic bottleneck, especially when zoonosis occurs10. This has been demonstrated 
experimentally by sequencing viral populations at the site of infection in one host as well as the 
recipient in which a narrowing of genetic diversity has occurred within and between host 
quasispecies11. Co-infection presents many logistical issues during viral replication. Replication 
complexes comprised of heterogeneous polymerase subunits derived from either virus likely 
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form, potentially altering the copy number of certain segments. It is unknown if heterogeneous 
polymerase complexes faithfully replicate genome segments to the same extent as a homogenous 
complex; if not, the rate of spurious mutations may increase during the initial and subsequent 
rounds of infection following the original co-infection event and increasing again the diversity of 
a quasispecies. Similarly, when the mutation rate is enhanced, or a large proportion of genome 
segments are defective, reassortment between strains may be enhanced12. 
 
Figure 5.1. IAV co-infection may produce progeny viruses that possess mixed 
genomes through reassortment. When two parent viruses co-infect a cell (left), prior 
to the initiation of genome replication (right),  generation of progeny IAV containing 
different combinations of genome segments (256 possible combinations) may occur. In 
addition to reassortment, or acquisiton of a new genome constellation component, the 
error prone polymerase of IAV may introduce mutations to genome segments during 
replication that alter the fitness of viruses in which they are packaged.  
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5.4  Decoding reassortment potential  
Numerous studies demonstrate that protein compatibility is not the sole driver of 
reassortment potential despite critical interactions required for replication13–16. Additional studies 
indicate the potential for a segment-segment interaction network as a mechanism of genome 
packaging and therefore determinant of reassortment17–21. However, a theoretical problem in the 
field has persisted since a genome segment was first imaged in the 1970s22. The overwhelming 
majority of viral RNA should be bound tightly by nucleoprotein according to prevailing 
models23.  
 This binding, if complete, would likely impede the formation of segment-segment 
interactions. However, others have shown the requirement for specific RNA features in IAV. 
This discord between the requirement for and ability to form RNA features drove our 
experimental design for the work described in Chapter 4. While we, and others, have reached 
similar conclusions pertaining to the interaction of NP and viral RNA, further investigation 
should be undertaken to complete the scaffolding our work has provided24.  
To determine how genetic interaction between diverse viruses occurs during co-infection, 
experiments to determine if vRNPs can be comprised of heterogeneous NP monomers from 
multiple viruses should be undertaken and if NPs from different strains interact with the same 
vRNA equivalently. Correspondingly, in the context of single virus and co-infection, the 
interaction network of vRNAs should be determined. Reassortment between closely related IAV 
occurs at high frequency and the rate of reassortment decreases, as segments are more divergent3.  
Certainly, a portion of reassortment rate is determined by protein-protein component 
interactions5,25–27, which allows efficient replication and overcome host restriction28,29, but the 
contribution of RNA-RNA interactions must be studied further. Here, I demonstrate that the 
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genetic and cellular context in which reassortment occurs couple to shape viral evolution. In 
chapter 2, I demonstrated that an avian H7N3 virus is capable of acquiring segments from the 
2009 pandemic that enhance pathogenesis in mice. However, many highly functional polymerase 
complexes, in vitro at least, are grossly attenuated when used to infect mice4. Despite protein 
compatibility, some additional function of these multifunctional proteins or underlying RNA 
features rendered these viruses incapable of efficient replication. Chapter 3 addresses 
competitive incorporation of the same genome segments in a different genome constellation. We 
found stark differences in selection preferences of multiple segments, indicating that the genetic 
context in which reassortment occurs determines the output progeny that are able to cause 
subsequent infection. Surprisingly, manipulation of a single amino acid in one protein can alter 
the outcome of engineered reassortment experiments, as can alteration of the constituent genetic 
backbone in which these experiments take place. The constituent proteome of closely related 
host species, and even tissue and cell types within a specific organism are different. Differences 
in host proteins that may be utilized by the virus or more likely the presence of specific host 
restriction factors and strain-specific antagonists may drive virus evolution. Specifically, the 
identity of this PA amino acid (184) has previously been coupled to the ability of a different 
virus strain to efficiently initiation transcription and overcome a host-adaptation block in human 
cells via altered interaction with the host MCM complex30,31. Coupled with the data generated in 
Chapter 3, a multifactorial model of reassortment barriers, supported by extensive data, may be 
constructed in which many viral components must be congruent for efficient emergence of a new 
virus. A model for the road to reassortment and barriers that must be overcome is presented in 
figure 5.2. In total, the studies described herein demonstrate that both genomic RNA and 
encoded proteins simultaneously contribute to the potential fitness landscape of influenza A 
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viruses during co-infection and conditions amenable to reassortment. 
 
Figure 5.2. Host and Virus-intrinsic restriction of IAV replication and 
reassortment potential. Block 1: IAV must bind, enter, and fuse within a host cell. 
For this to occur, the HA molecule must recognize specific sialic-acid moieties, 
while evading neutralizing antibody, and fuse in the endosome at low-pH.  Block 2: 
Transcription and replication, including nuclear import of newly synthesized viral 
proteins, are required for generation of progeny viruses. Host-specific factors are 
required for these processes and inadequate host-adaptation may preclude viral 
replication. Block 3: vRNP export and genome packaging are required for assembly 
of nascent viral particles. Efficient interaction between vRNAs are likely required 
for coordinated genome packaging and therefore may be a virus-intrinsic restriction 
of reassortment and evolution. (Figure adapted from Shi, et. al.1).  
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5.5 Recapitulating reassortment in a controlled manner 
Prior studies of reassortment relied upon cellular co-infection and a model in which all 
genome segments from parent viruses were present, yielding 28 (256) possible progeny. To 
simplify this model and isolate the specific segment-based requirements and restrictions of 
reassortment potential, we generated a co-transfection model to mimic reassortment in cell 
culture (Figure 1.1). The resulting mixture of virus was then genotyped to determine the 
preferences of reassortant segment selection in the context of two distantly related viral 
backbones. We saw that for the H7N3 backbone, mostly avian origin segments were selected 
with the notable exception of three segments from the  
2009 pandemic H1N1 virus. We then individually generated single gene reassortant 
viruses bearing seven segments of the avian virus and one segment from the pandemic virus. 
These viruses were characterized for their ability to replicate in tissue culture and in the lungs of 
mice. We found that substitution of three segments from the pandemic either did not alter the 
virulence of the H7N3 virus in mice. Interestingly, PB2 (segment 1) resulted in morbidity in 
mice surpassing that of the 2009 pandemic H1N1 itself. PB2 protein is known to be a 
determinant of host range and a number of protein coding changes present in the 2009 pandemic 
H1N1 PB2, but absent in the H7N3 PB2, allows increased replication in mammalian cells4. 
Additionally, the inclusion of NA (segment 6) or M (segment 7) segments from the 2009 
pandemic H1N1 did not attenuate the replication and pathogenesis profiles of the H7N3 virus. 
Either together or individually, these segments from the 2009 pandemic H1N1 increased 
transmission of previously non-transmissible viruses32,33. Therefore, it may be important to know 
if North American avian H7N3 viruses that possess HA receptor binding signatures similar to 
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human viruses, and bearing one of these segments, are capable of animal-to-animal 
transmission34. Future studies to examine the potential for reassortment between close and 
distantly related human, swine, and canine segments may be insightful given the they are all 
derived from an avian origin, but replicate in distinct mammalian hosts. However, biosafety and 
ethical considerations must be carefully examined prior to experimentation as a result of the 
Pause on Gain-of-Function studies that occurred from 2014-2016. While, the basic knowledge of 
advantageous adaptations may enhance disease surveillance, vaccine design, or accelerate 
antiviral discovery, the potential for nefarious use of constructive scientific information should 
be weighed with future efforts to understand what genetic features enable better replication or 
transmission of IAV in humans. 
5.6  Cartography of influenza A virus nucleoprotein-RNA interactions  
How nucleoprotein interacts with viral RNA in cells prior to and during genome 
packaging has not been addressed comprehensively at nucleotide resolution. Our studies indicate 
that NP protects approximately 12 nucleotides of viral genomic RNA inside human cells, and the 
profile of NP-binding to viral RNA is largely non-uniform. These findings agree with prior 
estimates of the RNase protected footprint of NP and biochemical experiments demonstrating the 
minimal length of RNA required for NP oligomerization in vitro35,36. The interaction of NP and 
viral RNA is highly reproducible, indicating some means of phasing NP across vRNA 
molecules. We propose that RNA structural elements, as well as steric constraints of the vRNP 
itself, likely determine the interaction of NP and vRNA. Approximately 10% of the viral genome 
is unbound at a given time and has potential to form RNA elements, both secondary and tertiary, 
required for viral replication and genome packaging.  NP, in either monomeric or dimeric form, 
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is added co-transcriptionally as PB1 synthesizes new viral RNA and coats a majority of the 
vRNA prior to nuclear export37,38. However, the addition of NP may be slower than the synthesis 
and processivity of PB1, allowing local RNA structure formation. In cases where a structure has 
a relatively stable fold, NP may be unable to deform the element and binds to the next adjacent 
available stretch of vRNA. The non-uniform landscape of NP-vRNA interactions suggests that 
these structural elements are important for the viral life cycle and corroborated by numerous 
mutagenesis and bioinformatics studies of sequence conservation in potentially structured 
regions39–42. An additional report of genome wide NP-vRNA association was published before 
the publication of our work and corroborates our findings in the context of two different virus 
strains24. A model to describe how favorable vRNA-vRNA interactions facilitate genome 
packaging, while sub-optimal interactions restrict genome packaging and reassortment is 
presented below (Figure 5.3) Taken together, these data suggest NP does not coat the entire IAV 
genome as previously hypothesized, and the unbound regions have required functions at a 
specific stage of infection.  
 
 
 
 
 
 
 
 167 
 
 
 
Figure 5.3. Model of vRNA-vRNA interactions required for IAV replication. IAV 
vRNA (blue) is bound by NP (light blue) as well as the polymerase complex of PB2 
(red), PB1(navy), and PA (green). NP does not bind all vRNA, leaving a portion of the 
genome exposed and able to form RNA features required for formation of a trans-
segment interaction network. Left: Presence of congruent RNA elements enable efficient 
genome packaging and potential genome reassortment. Right: Attenuation of segment-
segment interactions between non-congruent RNA elements suppresses genome 
packaging and the potential for co-packaging and reassortment of these segments. 
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5.7 Probing RNA structure in the viral genome 
Studies performed contemporaneously, by us and others, show the potential for NP to 
scaffold RNA structures, but there remains extremely limited biochemical and biophysical data 
for the authentic vRNA structure in the context of vRNPs. We hypothesize that certain RNA 
structures are present in NP unbound regions. However, biochemical evidence for any given 
native RNA structure to form in IAV is still lacking. Future investigations utilizing dimethyl 
sulfate reactivity mapping to identify what RNA bases are paired via high throughput sequencing 
of total viral RNA in various forms will be efficacious in determining the most populated 
structural elements43. Similarly, ongoing work in other laboratories utilizes SHAPE-seq to 
determine the reactivity and solvent accessibility of unpaired RNA bases44,45. Through personal 
communications, we discovered considerable correlation between our NP-unbound regions, and 
regions identified as unreactive to SHAPE reagents in the context of vRNPs, indicating NP does 
not bind highly structured elements. To elaborate on the function of these regions, we generated 
mutant viruses predicted to alter the fold of viral RNA in an isolated sequence. Probing if, and 
how, these changes in viral RNA alter RNA structure in isolation should also be undertaken. 
Utilization of methods including circular dichroism (CD) or small angle X-ray scattering (SAXS) 
may allow relative certainty that isolated NP-unbound regions do fold into specific structures and 
manipulation of the sequence in these regions augments the stability or structural envelope of the 
RNA.  Together, these studies may show that NP provides an energetically and biochemically 
regulated platform for RNA structure formation and interaction between segments, thereby 
enabling complete multi-segment assembly and infectious particle production.  
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5.8 NP-unbound regions with no known structure 
In addition to large, low-NP binding regions we identified a number of short areas in the viral 
genome with no known fold. Additional studies to examine the sequence requirements of these 
regions should be undertaken. While we looked for NP presence along the viral RNA, it is 
conceivable that the reproducible absence of NP is due to an additional host or viral factor that 
binds in a sequence specific manner at these sites. While these regions we identified appear to be 
of low structural complexity, a viral or host protein may compete off NP if it is present at great 
enough occupancy or has a significantly greater affinity for these specific sequences. 
Intriguingly, these short regions may also act as docking sites for larger structures from different 
segments through which a complex web of structured and unstructured elements interact to allow 
complete genome packaging.  
5.9 Expanding the genomewide landscape and interaction networks for IAV 
vRNA 
Evidence generated in our lab and others suggests vRNA features form a multi-segment 
interaction network13,46,47. Genome packaging is disrupted when mutations that are predicted to 
be structurally disruptive are introduced to virus, attenuating replication, and causing the loss of 
specific genome segments in total cell free virus, indicating interactions between may be 
required for genome assembly. We and others have described the interactions of NP and viral 
RNA in a limited set of IAV adapted to cell culture. Future studies must include a diverse array 
of IAV from human, swine, and avian sources in expanded studies on the NP-vRNA interaction. 
The nucleotide content of these viruses is unique and therefore each strain may have common as 
well as strain-specific RNA features protruding from the vRNP core. Analysis of additional 
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strain-specific elements may help elucidate how certain viruses tolerate slightly different levels 
of genome packaging efficacy as well as how likely it is for viruses containing congruous protein 
components to be generated following co-infection. In addition to mapping the scaffold of vRNA 
adorning the ribonucleoprotein complex, efforts should be made to biochemically assess the 
physical interaction network of viral RNAs with each other as well as with host RNA 
particularly given the association of multiple genome segments prior to packaging20,48. Recently, 
a number of proximity-dependent ligation and sequencing methods have been generated to allow 
access to nucleotide resolution maps of inter-RNA interaction networks49,50. Coupled with our 
knowledge of the basic NP-vRNA landscape – which enables determination of regions accessible 
for cross-segment interaction – specific mapping of the authentic network of sequence elements 
that contact one and other in cells and purified virus will yield the most complete understanding 
of how IAV packages a complete set of eight segments with high effectiveness.  As with these 
studies, once a basic network map for one virus is established, it should be expanded to 
determine if the contact points for both close and distant relatives of the prototype virus are 
shared or dependent on genomic context.  
5.10 Utilizing genome architecture data to monitor IAV evolution and guide 
treatment 
 Mapping the genetic structure and interaction network of IAV provides insight into the 
mechanisms of genome packaging and potential for reassortment. Computational models may be 
developed in the future to address the likelihood of productive interaction between vRNA that 
has been identified in nature and co-circulate geographically. In addition to the abundance of 
knowledge on protein features required for successful interaction of viral proteins, a predictive 
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model of reassortment success may be crafted to enable risk assessment of reassortant 
generation, if a large enough sample of virus genomes has been assessed by methods including 
PAR-CLIP and genome structure profiling. Additionally, therapeutics that target unstructured 
regions of vRNA with antisense oligos have been effectively utilized in vitro to target viral RNA 
for degradation, though the efficacy of these treatments in vivo has not been fully explored24,51. 
Finally, vaccination with live-attenuated viruses that retain all protein components, but 
reproducibly fail to replicate and package full genomes may enable generation of live-attenuated 
vaccines that evoke antibody as well as cell-mediated immunity52. Taken together, our 
understanding of how IAV RNA interacts between segments and if this interaction may be 
successfully translated to the clinic are exciting future directions.  
5.11 Understanding the multifaceted viral compatibility and host restriction 
of IAV. 
Herein, I have discussed three isolated but interconnected mechanisms that restrict the 
evolution and host adaptation of IAV. First, the genetic backgrounds of co-infecting viruses are a 
predominant driver of reassortment outcomes. Compatibility of viral proteins between strains, as 
well as RNA features, are capable of either enabling efficient reassortment or killing the possible 
formation of a new genome constellation. Second, the host environment in which co-infection 
occurs also dictates the potential for amplification of certain progeny genotypes. If a new 
reassortant combination is unable to subsequently replicate, or is attenuated relative to its parent, 
it will quickly disappear from the population at large. Conversely, the combination of multiple 
advantageous mutations, including escape from host immunity or enhanced utilization of a 
species-specific and required host factor, in a new constellation may enhance the ability of this 
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combination to spread throughout an organism, potentially leading to endemicity or pandemicity. 
Finally, congruence between RNA features, scaffolded by NP at the stage of genome packaging 
likely precludes the generation of multiple viruses despite compatible protein components. 
Together, these layers of complexity shape the evolutionary trajectories of IAV as well as the 
potential for emergence of novel genome constellations in animal and human populations. The 
research presented here adds to the growing understanding of how IAV successfully replicates in 
diverse hosts, with great and expanding genetic diversity, and elucidates some of the specific 
molecular mechanisms by which this pathogen continues to be an annual concern for animal and 
human health. 
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